edetic acid has been researched along with pyridoxal phosphate in 292 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (12.33) | 18.7374 |
| 1990's | 102 (34.93) | 18.2507 |
| 2000's | 121 (41.44) | 29.6817 |
| 2010's | 28 (9.59) | 24.3611 |
| 2020's | 5 (1.71) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, J; Rosenfeld, HJ | 1 |
| Florianowicz, T; Galas, E | 1 |
| Murphy, AJ | 1 |
| Gold, G; Widnell, CC | 1 |
| Aprison, MH; Daly, EC; Nadi, NS | 1 |
| Hoshino, S; Wakita, M | 1 |
| Blanco, I; Grau, M; Mengod, G; Palacios, JM; Picatoste, F | 1 |
| Eibl-Eibesfeldt, B; Hammerstingl, R; Lissner, J; Peqios, W; Schnell, B; Vogl, TJ | 1 |
| Branding, G; Hamm, B; Lissner, J; Schnell, B; Taupitz, M; Vogl, TJ; Wolf, KJ | 1 |
| Rofsky, NM; Weinreb, JC | 1 |
| Aicher, KP; Claussen, CD; Grönewäller, EF; Kopp, AF; Laniado, M | 1 |
| Bernardino, ME; Lee, JK; Weinreb, JC; Young, SW | 1 |
| Hartlapp, J; Kraheck, H; Layer, G; Reiser, M; Steudel, A | 1 |
| Berthezène, Y; Brasch, RC; Clément, O; Mühler, A; Rosenau, W; Vexler, V | 1 |
| Peters, PE; Rummeny, EJ | 1 |
| Saini, S | 1 |
| Muller, HH; Rubin, DL; Young, SW | 2 |
| Eibl-Eibesfeldt, B; Hamm, B; Lissner, J; Schnell, B; Steiner, S; Vogl, TJ | 1 |
| Ehrenheim, C; Gehl, HB; Hamm, B; Laniado, M; Lodemann, KP; Rummeny, E; Schmiedel, E; Steudel, A; Vogl, TG | 1 |
| Bernardino, ME; Lee, JK; Weinreb, J; Young, SW | 1 |
| Bernardino, ME | 1 |
| Chen, MC; Elizondo, G; Ferrucci, JT; Fretz, CJ; Quay, SC; Rocklage, SM; Stark, DD; Tsang, YM; Worah, D | 1 |
| Leese, PT; Lim, KO; Pfefferbaum, A; Quay, SC; Rocklage, SM; Stark, DD | 1 |
| Gehl, HB; Günther, RW; Klose, KC; Vorwerk, D | 1 |
| Bernardino, ME; Chezmar, JL; Gedgaudas-McClees, RK; Malko, JA; Nelson, RC; Newberry, LB | 1 |
| Beliaeva, NF; Nikulin, IR | 1 |
| Higgins, CB; Saeed, M; Takehara, Y; Wendland, MF | 1 |
| Lippi, G; Lippi, U; Modena, N; Nicoli, M; Schinella, M | 1 |
| Bradley, B; Muller, HH; Rubin, DL; Young, SW | 1 |
| Elizondo, G; Fretz, CJ; Stark, DD | 1 |
| Golman, K; Holtz, E; Klaveness, J; Leander, P; Leunbach, I; Olsson, M | 1 |
| Keleti, T; Leoncini, R; Marinello, E; Pagani, R | 1 |
| Edwards, P; Liu, PK; Rose, GA | 1 |
| Derugin, N; Finkbeiner, WE; Higgins, CB; Saeed, M; Wagner, S; Wendland, MF | 1 |
| Derugin, N; Higgins, CB; Holt, WW; Pomeroy, OH; Quay, S; Rocklage, SM; Wagner, S; Wendland, M | 1 |
| Carter, EA; Matkin, C; Ratner, AV; Simpson, BB; Young, SW | 1 |
| Airaksinen, MM; Gynther, J; Lapinjoki, SP; Peura, P | 1 |
| Grasso, JA; Hillis, TJ; Mooney-Frank, JA | 1 |
| Bottomley, SS; Self, J; Tanaka, M | 1 |
| Block, AM; Sagardía, F; Santiago, D; Santiago, PA | 1 |
| Murali, DK; Radhakrishnan, AN | 1 |
| Andrews, MJ; Turner, JM | 1 |
| Bottomley, SS; Smithee, GA | 1 |
| Nakashima, K; Ogino, K | 1 |
| Blasi, F; Covelli, I; Fragomele, F | 1 |
| Aoki, Y; Nakao, K; Takaku, F; Wada, O; Yano, Y | 1 |
| Hill, JM; Mann, PJ | 1 |
| Conn, EE; Floss, HG; Hadwiger, L | 1 |
| Hill, JM | 1 |
| Crews, L; Mazelis, M | 1 |
| Goldberg, A; Morrow, JJ; Urata, G | 1 |
| Baumgarten, J; Schlegel, HG | 1 |
| Burg, G | 1 |
| Gupta, YP | 1 |
| Brashear, RE; Compton, MC; Li, TK; Lumeng, L; Schenker, S | 1 |
| Kappel, WK; Olson, RE | 1 |
| Berg, K; Brurok, H; Jynge, P; Karlsson, JO; Schjøtt, J; Schøjtt, J | 1 |
| Chezmar, JL; Matteucci, T; Mitchell, DG; Outwater, EK; Rubin, DL; Saini, S | 1 |
| Grant, D; Holtz, E; Zech, K | 1 |
| Baba, Y; Chen, J; Kreft, BP; Lerch, MM; Saluja, AK; Stark, DD; Steer, ML; Tanimoto, A; Zhao, L | 1 |
| Asplund, A; Grant, D; Karlsson, JO | 1 |
| el-Rahmany, TA | 1 |
| Aggeler, J; Jones, AL; Muller, HH; Sidhu, MK; Young, SW | 1 |
| Borrello, JA; Brown, JJ; Lee, JK; Liou, J | 1 |
| Baert, AL; Lodemann, KP; Marchal, G; Michiels, J; Ni, Y; Rummeny, E; Van Hecke, P; Yu, J; Zhang, X | 1 |
| Baert, AL; Marchal, G; Ni, Y; Van Hecke, P; Yu, J; Zhang, X | 1 |
| Baert, AL; Lodemann, KP; Marchal, G; Ni, Y; Rummeny, E; Yu, J; Zhang, X | 1 |
| Bernardino, ME; Lee, JK; Noz, ME; Rofsky, NM; Weinreb, JC; Young, SW | 1 |
| Gehl, HB; Günther, RW; Hauptmann, S; Klever, P | 1 |
| Bohndorf, K; Gehl, HB; Günther, RW; Hauptmann, S; Klever, P; Lodemann, KP; Matern, S; Schumpelick, V; Urhahn, R | 1 |
| Chezmar, JL; Dillehay, DL; Garrison, MH; Nelson, RC; Spencer, HB; Thompson, GH; Webber, JB | 1 |
| Mitchell, DG | 1 |
| Blazak, WF; Gray, TJ; Treinen, KA | 1 |
| Baron, RL; Confer, SR; Davis, PL; Federle, MP; Murakami, T; Oliver, JH; Peterson, MS | 2 |
| Earls, JP; Rofsky, NM | 1 |
| Kettritz, U; Semelka, RC | 1 |
| Eisenberg, PJ; Hahn, PF; Mayo-smith, WW; Saini, S; Sharma, P; Slater, GJ | 1 |
| Bacic, G; Gallez, B; Swartz, HM | 1 |
| Colet, JM; Herrent, P; Muller, RN; Pamart, L; Séghi, F; van Haverbeke, Y; Vander Elst, L | 1 |
| Chezmar, JL; Redvanly, RD; Sewell, CW | 1 |
| Hua, J; Khangure, MS | 1 |
| Brown, ED; Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Warshauer, DM | 1 |
| Blazak, WF; Brown, GL; Denny, KH; Gray, TJ; Treinen, KA | 1 |
| Besjakov, J; Ege, T; Leander, P; Månsson, S | 1 |
| Bruneton, JN; Chevallier, P; Drouillard, J; Gordon, P; Lambrechts, M; Lecesne, R; Padovani, B; Raffaelli, C | 1 |
| Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Wilbur, K | 1 |
| Adline, J; Baudelet, C; Charbon, V; Gallez, B; Lambert, DM | 1 |
| Berg, K; Brurok, H; Jynge, P; Karlsson, JO; Schjøtt, J | 1 |
| Adline, J; Baudelet, C; Delzenne, N; Gallez, B; Geurts, M | 1 |
| Friisk, GA; Skotland, T; Toft, KG | 1 |
| Kindberg, GM; Skotland, T; Toft, KG | 1 |
| Grant, D; Marchal, G; Refsum, H; Rummeny, E | 1 |
| Bjerknes, HS; Gordon, PB; Lundby, B; McGill, S; Sterud, AT; Torres, CG | 1 |
| Kurdziel, JC; Lundby, B; Nilsen, G; Op de Beeck, B; Rummeny, EJ; Torres, CG | 1 |
| Ahlström, H; Ekholm, S; Fagertun, H; Hellström, M; Hemmingsson, A; Holtås, S; Isberg, B; Jonnson, E; Lönnemark-Magnusson, M; McGill, S; Wallengren, NO; Wang, C; Westman, L | 1 |
| Ayton, V; Benjamin, I; Heaton, ND; Kane, PA; Karani, JB; Walters, HL; Williams, R | 1 |
| Anglade, MC; Coffin, C; Lonjedo, E; Marti-Bonmati, L; Mathieu, D; Poyatos, C | 1 |
| Ahlström, H; Gehl, HB | 1 |
| Ahlström, H; Gordon, PB; Grant, D; Hemmingsson, A; Hustvedt, SO; Martinsen, I; Sterud, AT; Wang, C | 1 |
| Friisk, GA; Gordon, PB; Grant, D; Hustvedt, SO; Korsmo, AJ; Martinsen, I; Skotland, T; Toft, KG | 1 |
| Grant, D; Hustvedt, SO; Southon, TE; Zech, K | 1 |
| Baert, AL; Bosmans, H; Grant, D; Marchal, G; Miao, Y; Ni, Y; Petré, C | 1 |
| Bjørnerud, A; Grant, D; Martinsen, I; Moen, OM; Refsum, H; Southon, TE; Spilling, B | 1 |
| Isberg, B; Jorulf, H; Svahn, U; Thorstensen, O; Venizelos, N; Westman, L | 1 |
| Marchal, G; Ni, Y | 1 |
| Atzpodien, E; Grant, D; Martinsen, I; Toft, KG | 1 |
| Asplund, A; Brurok, H; Jynge, P; Karlsson, JO; Refsum, H; Towart, R | 1 |
| Karlsson, JO; Mortensen, E; Pedersen, HK; Refsum, H; Sager, G | 1 |
| Blazak, WF; Brown, GL; Grant, D | 1 |
| Grant, D; Larsen, LE | 1 |
| Aukrust, A; Couture, E; Grace, D; Haile, Y; Holm, KM; Hope, H; Larsen, A; Lunde, HS; Sjøgren, CE; Tirkkonen, B | 1 |
| Colet, JM; Muller, RN; Vander Elst, L | 1 |
| Aue, B; Blume, J; Heller, M; Lodemann, KP; Palmié, S; Sievers, E; Spielmann, RP | 1 |
| Baert, AL; Grant, D; Gray, TJ; Lukito, G; Marchal, G; Ni, Y; Petré, C | 1 |
| Kopp, AF; Laniado, M | 1 |
| Mayo-Smith, WW; McFarland, EG; Saini, S; Schima, W; Slater, GJ | 1 |
| Hahn, PF; Saini, S | 1 |
| Wang, C | 1 |
| Goyal, A; Katiyar, SS | 1 |
| Casillas, C; Lonjedo, E; Martí-Bonmatí, L; Poyatos, C | 1 |
| Fischbach, R; Heindel, W; Jung, G; Klaus, H; Krahe, T; Kugel, H; Lackner, K; Walter, C | 1 |
| Ardenkjaer-Larsen, JH; Berg, K; Brurok, H; Hansson, G; Jynge, P; Karlsson, JO; Laursen, I; Skarra, S | 1 |
| Arheden, H; Bremerich, J; Geschwind, JF; Higgins, CB; Saeed, M; Wendland, MF; Wyttenbach, R | 1 |
| Ahlström, H; Fagertun, H; Johansson, L; Wang, C; Western, A | 1 |
| Alam, F; Mitchell, DG | 1 |
| Alexandre, M; Caseiro-Alves, F; Coffin, CM; Diche, T; Mahfouz, A; Mathieu, D; Rahmouni, A; Vasile, N | 1 |
| Berg, K; Brurok, H; Grant, D; Jynge, P; Karlsson, JO; Sneen, L | 1 |
| Caseiro-Alves, F; Coffin, C; Diche, T; Kobeiter, H; Mahfouz, A; Mathieu, D; Rahmouni, A | 1 |
| Diehl, SJ; Gaa, J; Georgi, M; Hoffmann, V; Lehmann, KJ; McGill, S | 1 |
| Berg, K; Brurok, H; Jynge, P; Karlsson, JO; Skarra, S; Skoglund, T | 1 |
| Higgins, CB; Lund, G; Saeed, M; Wendland, MF | 1 |
| Clément, O; Cuénod, CA; Frija, G; Leconte, I; Siauve, N; Vuillemin-Bodaghi, V | 1 |
| Arheden, H; Bremerich, J; Higgins, CB; Saeed, M; Wendland, MF | 2 |
| Anderson, MW; Borello, JA; Bova, JG; Brown, JJ; Chezmar, JL; Dachman, AH; Federle, MP; Fenstermacher, M; Foster, GS; Francis, IR; Freeny, PC; Halford, HH; Harmon, B; Harms, SE; Johnson, CD; Kenney, PJ; Klippenstein, DL; Lee, JK; Mattrey, R; Mitchell, DG; Pelsang, RE; Rubin, DL; Saini, S; Semelka, RC; Turner, DA; Weinreb, JC | 1 |
| Runge, VM | 1 |
| Laméris, JS; Romijn, MG; Stoker, J; Torres, CG; van Eijck, CH; van Muiswinkel, JM | 1 |
| Anderson, MW; Ballerini, R; Bennett, WF; Borrello, JA; Brown, JJ; Chezmar, J; Dachman, AH; Federle, M; Freeny, P; Gay, SB; Halford, HH; Harms, SE; Lee, JK; Mattrey, R; Mitchell, DG; Rifkin, M; Robison, RO; Rubin, DL; Saini, S; Schmiedl, UP; Semelka, RC; Sherwin, PF; Weinreb, J; Young, SW | 1 |
| Bartolozzi, C; Cioni, D; Crocetti, L; Donati, F; Lencioni, R | 1 |
| Balci, NC; Chung, JJ; Martin, DR; Semelka, RC; Wilber, K | 1 |
| Brambs, HJ; Klaus, H; Nüssle, K; Rieber, A; Tomczak, R | 1 |
| Burkill, GJ; Healy, JC; Mannion, EM | 1 |
| de Jode, M; Gedroyc, WM; Joarder, R; Lamb, GA | 1 |
| Berman, P; Krinsky, GA; Lee, VS; Morgan, GR; Rofsky, NM; Teperman, LW; Weinreb, JC | 1 |
| Døhl, J; Gjerde, H; Hem, H; Larsen, KH; Snøtun, A | 1 |
| Biederer, J; Blume, J; Grimm, J; Heller, M; Müller-Hülsbeck, S | 1 |
| Myrset, AH; Skotland, T; Toft, KG | 1 |
| Lai, LL; Mann, GN; Marx, HF; Wagman, LD | 1 |
| Flemming, P; Galanski, M; Högemann, D; Kreipe, H | 1 |
| Eracleous, E; Gogas, C; Gourtsoyiannis, N; Maris, T; Papanikolaou, N; Prassopoulos, P | 1 |
| De Cobelli, F; De Gaspari, A; Del Maschio, A | 1 |
| Helmberger, T; Semelka, RC | 1 |
| Smith, HJ | 1 |
| Brurok, H; Engebretsen, B; Eriksen, M; Jynge, P; Karlsson, JO; Moen, O; Refsum, H; Toft, KG; Towart, R | 1 |
| Döhring, W; Helmberger, TK; Jung, G; Laubenberger, J; Meurer, K; Reiser, MF; Rummeny, E; Sievers, K | 1 |
| de Hemptinne, B; Elewaut, A; Mortelé, KJ; Praet, M; Ros, PR; Wiesner, W | 1 |
| Ballerini, R; Bhat, S; Brown, J; Chezmar, J; Francis, IR; Getty, DJ; Harmon, B; Mattrey, RF; Pickett, RM; Saini, S; Schnall, MO; Seltzer, SE; Sica, G; Siegelman, ES; Swets, JA | 1 |
| Andersson, K; Schmidt, PP; Skotland, T; Toft, KG | 1 |
| de Groot, JC; Fernandez-Cuadrado, J; Grimm, J; König, M; Marquardt, M; Op de Beeck, B; Oudkerk, M; Song, B; Torres, CG; van Dijk, P | 1 |
| Bluemke, DA; Braga, HJ; Choti, MA; Lee, VS; Paulson, EK; Siegelman, ES | 1 |
| Gogas, C; Gourtsoyiannis, N; Maris, T; Mouzas, J; Papanikolaou, N; Prassopoulos, P | 1 |
| Baum, U; Bautz, W; Dobritz, M; Fellner, FA; Klein, P; Lell, M; Nömayr, A; Papadopoulos, T | 1 |
| Bennett, WF; Bova, JG; El-Dieb, A; Ellison, C; Fromkes, J; Vaswani, KK; Vitellas, KM | 1 |
| Függer, R; Grabenwöger, F; Novacek, G; Oettl, C; Ryan, JM; Schima, W; Schober, E; Wamser, P | 1 |
| Choi, D; Kim, H; Kim, SH; Kim, SK; Lee, SJ; Lee, WJ; Lim, HK; Lim, JH; Seo, JW | 1 |
| Hahn, PF; Kalra, MK; Michael, M; Sahani, DV; Saini, S | 1 |
| Adriaens, P; Bogaert, J; Bosmans, H; Cresens, E; Dymarkowski, S; Marchal, G; Ni, Y; Verbruggen, A; Zhang, H | 1 |
| Baron, RL; Eghtesad, B; Fung, JJ; Kapoor, V; Patel, S; Peterson, MS | 1 |
| Gong, J; Shen, K; Xu, J; Zhou, K | 1 |
| Hemmingsson, A | 1 |
| Körner, M; Linsenmaier, U; Pfeifer, KJ; Rieger, J; Rock, C; Wirth, S | 1 |
| Ba-Ssalamah, A; Helbich, T; Kurtaran, A; Laengle, F; Linnau, KF; Mann, FA; Reimer, P; Ryan, M; Schibany, N; Schima, W; Schmook, MT; Wrba, F | 1 |
| Függer, R; Schima, W | 1 |
| Harnish, P; Lanigan, T; Li, W; Prasad, PV; Rofsky, NM; Seoane, P; Storey, P; Zuo, CS | 1 |
| Burkill, GJ; Healy, JC; King, LJ; Scurr, E | 1 |
| Burkill, GJ; Healy, JC; King, LJ; Murray-Lyons, I; Scurr, ED; Vlavianos, P | 1 |
| Abo-Ramadan, U; Aronen, H; Häkkinen, AM; Halavaara, J; Markkola, A | 1 |
| Schima, W | 1 |
| Chung, JP; Kim, KW; Lee, KH; Lee, KS; Lee, SI; Park, MS; Ryu, YH; Yoon, SW; Yu, JS | 1 |
| Chen, KM; Wang, DB; Wang, YX; Zeng, MS; Zhou, KR | 1 |
| Fishbein, T; Florman, S; Gerning, A; Goldman, J; Gondolesi, GE; Kim, L; Schwartz, ME; Varotti, G | 1 |
| de Beeck, BO; Fagertun, H; Fog, AF; Kane, P; Martí-Bonmatí, L | 1 |
| Dionne, G; Dufour, M; Godbout, MJ; Moisan, C; Morin, J; Serre, D; Traoré, AS; Younan, R | 1 |
| Aboalmaali, N; Hamoud, AK; Khan, MF; Usadel, KH; Vogl, TJ; Wullstein, C | 1 |
| Chang, RM; Guo, T; Zhang, XL; Zhang, YZ | 1 |
| ADAMS, E; NORTON, IL | 1 |
| DIVEN, WF; JOHNSTON, RB; SCHOLZ, JJ | 1 |
| ALBRECHT, AM; VOGEL, HJ | 1 |
| ROBINSON, JD | 1 |
| Bergin, D; Curcillo, PG; Fayad, LM; Holland, GA; Intenzo, C; Iqbal, N; Kowalski, TE; Mitchell, DG; Park, P; Parker, L | 1 |
| Aurdal, L; Clausen, OP; Edwin, B; Frich, L; Gladhaug, I; Mala, T; Soreide, O | 1 |
| Batteux, F; Bedda, S; Calmus, Y; Chéreau, C; Conti, F; Goulvestre, C; Jaffray, P; Laurent, A; Soubrane, O; Tran, A; Tran-Van Nhieu, J; Weill, B | 1 |
| Bartolozzi, C; Chiesa, A; Cioni, D; Cittadini, G; Donati, F; Gandini, G; Giovagnoni, A; Grazioli, L; Lencioni, R; Maass, J; Morana, G; Procacci, C | 1 |
| Reimer, P; Schima, W; Schneider, G | 1 |
| Breiman, RS; Coakley, FV; Qayyum, A; Roberts, JP; Taouli, B; Yeh, BM | 1 |
| Crozon, J; Gruner, L; Pilleul, F; Valette, PJ; Viremouneix, L | 1 |
| Baus, S; Galanski, M; Gratz, KF; Köstler, H; Mössinger, M; Savellano, DH; Weimann, A | 1 |
| Karlsson, JO | 1 |
| Ha, HK; Kim, AY; Kim, HJ; Kim, JC; Kim, KW; Kim, PN; Kim, TK; Lee, MG; Lee, YK; Park, MS; Park, SH | 1 |
| Ahlström, H; Bjerner, T; Briley Saebo, K; Eriksson, R; Johansson, L | 1 |
| Bridges, MD; Harnois, DM; May, GR | 1 |
| Harnish, PP; Hu, J; Rofsky, NM; Seoane, PR; Zuo, CS | 1 |
| Billaud, Y; Crombé-Ternamian, A; Fouque, P; Gautier, G; Monneuse, O; Pilleul, F; Valette, PJ | 1 |
| Beziat, C; Lombard-Bohas, C; Mercier, C; Pilleul, F; Valette, PJ; Yzebe, D | 1 |
| Cullingford, G; Edmunds, S; Fletcher, D; Marshall, M; Mendelson, R; Ramsay, D; Song, S; Yusoff, I; Zimmerman, M | 1 |
| Allan, L; Houston, JG; Martin, P; McLeay, T; Milne, W; Sheppard, D | 1 |
| Boccuni, R; Brambilla, P; Del Maschio, A; Di Carlo, V; Nicoletti, R; Staudacher, C; Zanello, A | 1 |
| Kim, CS; Lee, JM; Youk, JH | 1 |
| Choi, JS; Chung, JJ; Kim, JH; Kim, KW; Kim, MJ; Lee, WJ; Lim, JS; Oh, YT | 1 |
| Ayuso, C; Ayuso, JR; Bombuy, E; Bruix, J; De Caralt, TM; De Juan, C; García-Valdecasas, JC; Llovet, JM; Pagés, M; Sánchez, M | 1 |
| Babb, JS; Chang, JS; Krinsky, GA; Lee, VS; Lin, JC; Morgan, GR; Nazzaro, CA; Teperman, LW | 1 |
| Cho, ES; Ha, HK; Kim, KW; Kim, MJ; Kim, TK; Lee, JD; Lee, JT; Lee, SI; Lee, WJ; Lim, JS; Park, MS; Yoo, HS; Yoon, DS; Yu, JS | 1 |
| Ba-Ssalamah, A; Dirisamer, A; Happel, B; Kettenbach, J; Längle, F; Schima, W; Wrba, F | 1 |
| Haraldseth, O; Jynge, P; Kristoffersen, A; Larsson, HB; Skjold, A; Vangberg, TR | 2 |
| Choi, JW; Gong, GY; Kim, ST; Kim, TH; Lim, TH; Seo, JB; Shin, JH; Yang, DH; Yoon, JH | 1 |
| Choi, JW; Kim, ST; Kim, TH; Lim, TH; Seo, JB; Shin, JH; Yang, DH; Yoon, JH | 1 |
| Crossgrove, J; Zheng, W | 1 |
| Milot, L; Partensky, C; Pilleul, F; Scoazec, JY; Valette, PJ | 1 |
| Choe, BH; Kang, DS; Kim, HM; Kim, JY; Ko, CW; Kwon, S; Lee, SB; Ryeom, HK | 1 |
| Bourgeois, N; Devière, J; Hottat, N; Matos, C; Metens, T; Winant, C | 1 |
| Bluemke, DA; Fayad, LM; Kamel, IR; Mitchell, DG | 1 |
| Boraschi, P; Campori, G; Donati, F; Volpi, A | 1 |
| Blake, M; Fischman, AJ; Hahn, PF; Kadavigere, R; Kalva, SP; Sahani, DV; Saini, S | 1 |
| Fischman, AJ; Hahn, PF; Kalva, SP; Mueller, P; Ryan, D; Sahani, DV; Saini, S | 1 |
| Chabanova, E; Løgager, V; Møller, JM; Thomsen, HS | 1 |
| Kuribayashi, S; Tanimoto, A | 1 |
| Brurok, H; Jynge, P; Karlsson, JO; Towart, R | 1 |
| Goshima, S; Hirose, Y; Kanematsu, M; Kato, H; Kim, MJ; Kondo, H; Moriyama, N; Tsuge, U | 1 |
| Assaban, M; Aubé, C; Caron, C; Hamy, A; Lebigot, J; Ridereau-Zins, C | 1 |
| Bartolozzi, C; Boggi, U; Boraschi, P; Caramella, D; Donati, F; Falaschi, F; Gigoni, R | 1 |
| Doroshow, JH | 1 |
| Alexandre, J; Batteux, F; Chéreau, C; Goldwasser, F; Laurent, A; Nicco, C; Weill, B | 1 |
| Aglietta, M; Anselmetti, GC; Campanella, D; Capussotti, L; Cirillo, S; Floriani, I; Galatola, G; Gallo, TM; Muratore, A; Regge, D | 1 |
| Byun, JH; Kim, HJ; Kim, KW; Kim, PN; Lee, MG; Lee, MS; Shin, YM; Won, HJ | 1 |
| Chung, JJ; Kim, KW; Kim, MJ | 1 |
| Eser, C; Eser, G; Karabacakoglu, A; Karakose, S; Kayacetin, E | 1 |
| Choi, JY; Chung, JJ; Kim, JH; Kim, KW; Kim, MJ; Kim, SH; Ko, HK; Lee, JT; Lim, JS; Oh, YT; Yoo, HS | 1 |
| Adigüzel, Y; Haykir, R; Karabacakoğlu, A; Karaköse, S; Kayaçetin, E | 1 |
| Brown, G; Husband, JE; Koh, DM; Meer, Z; Norman, AR | 1 |
| Rummeny, EJ; Settles, M; Weirich, G; Wiener, E; Woertler, K | 1 |
| Barbary, C; Béot, S; Corby, S; Kermarrec, E; Laurent, V; Régent, D | 1 |
| Bryant, M; Higginson, A | 1 |
| Amundsen, BH; Haraldseth, O; Jynge, P; Larsson, HB; Skjold, A; Støylen, A; Wiseth, R | 1 |
| Berry, M; Brekken, C; Goa, PE; Haraldseth, O; Kovalev, V; Olsen, Ø; Petrou, M; Sandvig, A; Thuen, M | 1 |
| Allen, SD; Brown, G; Chau, I; Collins, DJ; Cunningham, D; deSouza, NM; Husband, JE; Koh, DM; Leach, MO; Riddell, AM; Scurr, E | 1 |
| Durieux, M; Ficarelli, S; Kamaoui, I; Mennesson, N; Milot, L; Pilleul, F | 1 |
| Bocchi, C; Corradi, D; De Filippo, M; Quartieri, L; Zompatori, M | 1 |
| Brown, G; Cook, GJ; Cunningham, D; Jackson, C; Koh, DM; Kong, G; Lewington, V; Sharma, B | 1 |
| Choi, JS; Chung, JB; Kim, BR; Kim, JH; Kim, KS; Kim, KW; Kim, MJ; Lee, JT; Park, YN | 1 |
| Grossman, AB; Monson, JP; Nowosinska, E; Planche, K; Power, N; Reznek, RH; Rockall, AG | 1 |
| Hegstad, E; Hovde, O; Jynge, P; Pignon, I; Vig, J; Yri, OE | 1 |
| Bartolozzi, C; Boggi, U; Boraschi, P; Del Chiaro, M; Donati, F; Faggioni, L; Falaschi, F; Gigoni, R; Salemi, S | 1 |
| Bosmans, H; Chen, F; DeKeyzer, F; Feng, Y; Li, J; Marchal, G; Ni, Y; Wang, H; Yu, J | 1 |
| Berkowitz, BA; Jin, Y; Porchia, A; Roberts, R; Tofts, PS | 1 |
| Batteux, F; Debray, M; Hirt, D; Laurent, A; Pavlovic, S; Poupon, J; Richardet, JP; Sogni, P; Treluyer, JM; Urien, S; Weill, B | 1 |
| Catalano, OA; Hahn, PF; Sahani, DV; Saini, S; Seale, MK | 1 |
| Wu, EX; Yang, J | 1 |
| Ba-Ssalamah, A; Gruenberger, T; Kaczirek, K; Kulemann, V; Schima, W; Tamandl, D; Weber, M; Wrba, F | 1 |
| Andersson, RG; Laskar, A; Li, W; Miah, S | 1 |
| Bertin, A; Felder-Flesch, D; Gallani, JL; Michou-Gallani, AI | 1 |
| Camera, L; Fusari, M; Imbriaco, M; Maurea, S; Mollica, C; Salvatore, M | 1 |
| Batteux, F; Bedda, S; Chereau, C; Coriat, R; Goulvestre, C; Kavian, N; Laurent, A; Leconte, M; Nicco, C; Weill, B | 1 |
| Bae, K; Cho, JM; Choi, DS; Choi, HC; Choi, HY; Chung, SH; Jeon, KN; Kim, JE; Na, JB; Park, MJ | 1 |
| Carpani, G; Cattaneo, M; Femia, EA; Gresele, P; Mezzasoma, AM; Podda, GM; Pugliano, M | 1 |
| Betts-Henderson, J; Cleary, JO; Lythgoe, MF; McCue, K; Norris, FC; Salomoni, P; Scambler, PJ; Siow, BM; Walker-Samuel, S; Wells, JA | 1 |
| Ben Mosbah, I; Boudjema, K; Compagnon, P; Corlu, A; Laurent, A; Lucas, C; Morel, F; Mouchel, Y; Pajaud, J; Ribault, C | 1 |
| Alexander Grant, L; Burke, C; Goh, V; Griffin, N | 1 |
| Bodin, B; Gao, X; Jansson, L; Johansson, L; Quach, M; Sandberg, M | 1 |
| Andersson, RG; Laskar, A; Li, W | 1 |
| Grothey, A; Loprinzi, CL; Pachman, DR; Ta, LE | 1 |
| Alexandre, J; Batteux, F; Benoit, E; Borderie, D; Chéreau, C; Coriat, R; Coste, J; Goldwasser, F; Lemaréchal, H; Mir, O; Nicco, C; Quinquis, L; Tréluyer, JM; Weill, B | 1 |
| Näsström, J | 1 |
| Almén, T; Ignarro, LJ; Jynge, P; Karlsson, JO; Lundström, I | 1 |
| Batteux, F; Cerles, O; Nicco, C | 1 |
| Ali, M; Andersson, RG; El-Saadi, W; Engvall, JE; Jynge, P; Karlsson, JE; Maret, E; Puskar, W; Skogvard, P | 1 |
| Abisambra, JF; Cloyd, R; Vandsburger, M | 1 |
| Goto, M; Ishida, C; Iwase, A; Kato, N; Kikkawa, F; Kotani, T; Murase, T; Nakamura, T; Osuka, S; Qin, Y; Takikawa, S | 1 |
| Dear, J | 1 |
| Ignarro, LJ; Jynge, P; Karlsson, JOG; Lundström, I | 1 |
| Black, P; Dear, JW; Gallagher, B; Grahamslaw, J; Henriksen, D; Lee, RJ; Morrison, EE; O'Brien, R; Oatey, K; Oosthuyzen, W; Weir, CJ | 1 |
| Baker, AH; Dweck, MR; Newby, DE; Semple, SIK; Spath, NB; Thompson, G | 1 |
| Berkowitz, BA; Cortese, ICM; Dewey, B; Dwyer, JT; Koretsky, AP; Nair, G; Reich, DS; Steele, SU; Sudarshana, DM; Suto, DJ; Wu, T | 1 |
| Karlsson, JOG | 1 |
| Dear, JW | 1 |
| Freeman, WE; Mullins, ME; Yeager, LH | 1 |
| Beck, ES; Cortese, ICM; Dwyer, J; Koretsky, AP; McFarland, H; Nair, G; Ohayon, J; Reich, DS; Steele, SU; Sudarshana, DM; Suto, DJ | 1 |
| Akakpo, JY; Jaeschke, H; Ramachandran, A | 1 |
| Andersson, RGG; Blomlie, V; Bruvold, M; Eidsaunet, W; Falkmer, U; Jynge, P; Karlsson, JOG; Seland, JG; Skjold, AM | 1 |
| Baker, A; Dweck, MR; Janiczek, RJ; Kershaw, L; McCann, GP; Newby, DE; Papanastasiou, G; Semple, S; Singh, T; Spath, NB | 1 |
29 review(s) available for edetic acid and pyridoxal phosphate
| Article | Year |
|---|---|
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Topics: Adrenal Gland Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Edetic Acid; Female; Humans; Kidney Diseases; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Pancreatic Diseases; Pyridoxal Phosphate | 1996 |
Contrast-enhanced MR imaging of the pancreas.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Organometallic Compounds; Pancreas; Pancreas Transplantation; Pancreatic Diseases; Pancreatic Neoplasms; Pentetic Acid; Pyridoxal Phosphate | 1996 |
Overview of MnDPDP as a pancreas-specific contrast agent for MR imaging.
Topics: Acute Disease; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Manganese; Pancreas; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate; Reference Values | 1997 |
Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
Topics: Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Edetic Acid; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate | 1997 |
Cardiovascular safety of MnDPDP and MnCl2.
Topics: Animals; Cardiovascular System; Chlorides; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Humans; In Vitro Techniques; Manganese; Manganese Compounds; Manganese Poisoning; Pyridoxal Phosphate; Safety | 1997 |
General toxicology of MnDPDP.
Topics: Animals; Contrast Media; Dose-Response Relationship, Drug; Drug Tolerance; Edetic Acid; Female; Male; Manganese; Manganese Poisoning; Pyridoxal Phosphate; Skin Absorption | 1997 |
[Current status of the clinical development of MR contrast media].
Topics: Adult; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Iron; Lymphography; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Suspensions | 1997 |
Liver-specific MR imaging contrast agents.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxides; Pyridoxal Phosphate | 1998 |
Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
Topics: Adenoma, Islet Cell; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Preoperative Care; Pyridoxal Phosphate | 1999 |
Contrast-enhanced MRI for quantification of myocardial viability.
Topics: Animals; Contrast Media; Dysprosium; Edetic Acid; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Myocardial Ischemia; Myocardial Stunning; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1999 |
Mechanisms of action of liver contrast agents: impact for clinical use.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intravenous; Iron; Kupffer Cells; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 1999 |
Safety of approved MR contrast media for intravenous injection.
Topics: Anaphylaxis; Chelating Agents; Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intravenous; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Molecular Structure; Oxides; Pyridoxal Phosphate; Safety | 2000 |
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 2001 |
New contrast agents for imaging the liver.
Topics: Animals; Contrast Media; Edetic Acid; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2001 |
Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT.
Topics: Contrast Media; Edetic Acid; Humans; Laparotomy; Magnetic Resonance Imaging; Neoplasm Staging; Pancreatic Neoplasms; Pyridoxal Phosphate; Tomography, Spiral Computed; Ultrasonography, Interventional | 2002 |
Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis.
Topics: Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Retrospective Studies; Safety | 2003 |
Mangan-enhanced MR imaging for the detection and localisation of small pancreatic insulinoma.
Topics: Contrast Media; Edetic Acid; Humans; Insulinoma; Laparoscopy; Magnetic Resonance Imaging; Pancreas; Pancreatic Neoplasms; Pyridoxal Phosphate; Robotics | 2004 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
[MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
Topics: Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Practice Patterns, Physicians'; Pyridoxal Phosphate | 2004 |
Manganese toxicity upon overexposure.
Topics: Animals; Brain; Contrast Media; Edetic Acid; Heart; Humans; Manganese; Manganese Poisoning; Myocardium; Pyridoxal Phosphate | 2004 |
Functional MR cholangiography: diagnosis of functional abnormalities of the gallbladder and biliary tree.
Topics: Biliary Tract; Biliary Tract Diseases; Contrast Media; Edetic Acid; Gallbladder; Gallbladder Diseases; Humans; Magnetic Resonance Imaging; Pyridoxal Phosphate | 2005 |
Imaging liver metastases: review and update.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Hepatic Artery; Humans; Image Enhancement; Iron; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxides; Portography; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2006 |
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Topics: Bile Duct Neoplasms; Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2013 |
Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.
Topics: Animals; Antineoplastic Agents; Antioxidants; Biological Mimicry; Colorectal Neoplasms; Edetic Acid; Ethylenediamines; Humans; Manganese; Molecular Structure; Myocardial Infarction; Oxidative Stress; Percutaneous Coronary Intervention; Pyridoxal Phosphate; Reactive Oxygen Species; Structure-Activity Relationship; Superoxide Dismutase; Treatment Outcome | 2015 |
Manganese-enhanced MRI of the myocardium.
Topics: Animals; Calcium Signaling; Cardiomyopathies; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Manganese; Myocardium; Predictive Value of Tests; Prognosis; Pyridoxal Phosphate; Tissue Survival | 2019 |
Metabolic and mitochondrial treatments for severe paracetamol poisoning: a systematic review.
Topics: Acetaminophen; Acetylcysteine; Acidosis; Animals; Antidotes; Cimetidine; Drug Overdose; Edetic Acid; Fomepizole; Humans; Mitochondria; Pyridoxal Phosphate | 2020 |
Novel strategies for the treatment of acetaminophen hepatotoxicity.
Topics: Acetaminophen; Acetylcysteine; Animals; Antidotes; Chemical and Drug Induced Liver Injury; Drug Overdose; Edetic Acid; Fomepizole; Hepatocytes; Humans; Liver Failure, Acute; Pyridoxal Phosphate | 2020 |
MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
Topics: Brain; Contrast Media; Edetic Acid; Heart; Humans; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Retina | 2020 |
48 trial(s) available for edetic acid and pyridoxal phosphate
| Article | Year |
|---|---|
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Female; Humans; Image Processing, Computer-Assisted; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 1992 |
[Manganese DPDP as a contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20 patients].
Topics: Adult; Contrast Media; Drug Tolerance; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate | 1992 |
[Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent].
Topics: Adult; Aged; Contrast Media; Drug Evaluation; Edetic Acid; Humans; Infusions, Intravenous; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 1992 |
Hepatobiliary MR imaging: first human experience with MnDPDP.
Topics: Adult; Contrast Media; Drug Evaluation; Edetic Acid; Humans; Liver; Magnetic Resonance Imaging; Male; Manganese; Manganese Poisoning; Pyridoxal Phosphate | 1991 |
Adrenal gland enhancement at MR imaging with Mn-DPDP.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 1995 |
Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Pyridoxal Phosphate; Sensitivity and Specificity | 1993 |
[Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings].
Topics: Adenocarcinoma; Adenoma, Islet Cell; Chronic Disease; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 1993 |
Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
Topics: Adenocarcinoma; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Neoplasms; Pyridoxal Phosphate | 1993 |
Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Topics: Case-Control Studies; Contrast Media; Edetic Acid; Female; Humans; Image Processing, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 1996 |
Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Confidence Intervals; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate | 1996 |
Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 1996 |
Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: correlation with unenhanced imaging findings and histopathologic features.
Topics: Adult; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Necrosis; Pyridoxal Phosphate | 1996 |
Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
Topics: Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Tomography, X-Ray Computed | 1996 |
MnDPDP for MR imaging of the liver. Results from the European phase III studies.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Europe; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Safety | 1997 |
MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Europe; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate | 1997 |
Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Sweden | 1997 |
MnDPDP-enhanced MR imaging of the liver. Correlation with surgical findings.
Topics: Adolescent; Adult; Aged; Animals; Contrast Media; Edetic Acid; Female; Guinea Pigs; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate | 1997 |
Tumoural portal vein thrombosis. Enhancement with MnDPDP.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Neoplastic Cells, Circulating; Portal Vein; Pyridoxal Phosphate; Thrombosis | 1997 |
MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers.
Topics: Adult; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Humans; Kidney; Liver; Magnetic Resonance Imaging; Male; Manganese; Pancreas; Pyridoxal Phosphate; Reference Values; Single-Blind Method; Spleen; Time Factors | 1997 |
Pancreatic enhancement and pulse sequence analysis using low-dose mangafodipir trisodium.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Neoplasms; Pyridoxal Phosphate | 1998 |
MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers.
Topics: Aged; Chi-Square Distribution; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Statistics, Nonparametric | 1998 |
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
Topics: Adenoma, Liver Cell; Adult; Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Follow-Up Studies; Humans; Hyperplasia; Image Enhancement; Injections, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Retrospective Studies | 1999 |
MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
Topics: Adult; Aged; Carcinoma, Ductal, Breast; Chronic Disease; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 1999 |
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety).
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Image Enhancement; Injections, Intravenous; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pain; Pregnancy; Pyridoxal Phosphate; Risk Assessment; Sensitivity and Specificity; Vomiting | 2000 |
MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Image Processing, Computer-Assisted; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2000 |
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Image Enhancement; Injections, Intravenous; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2000 |
MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.
Topics: Carcinoma, Hepatocellular; Edetic Acid; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Prospective Studies; Pyridoxal Phosphate; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2000 |
MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2000 |
[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
Topics: Adenoma; Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cysts; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia; Humans; Liver; Liver Diseases; Liver Neoplasms; Liver Regeneration; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2001 |
MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast Media; Discriminant Analysis; Edetic Acid; Female; Hemangioma; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2002 |
Multimodality diagnosis of liver tumors: feature analysis with CT, liver-specific and contrast-enhanced MR, and a computer model.
Topics: Adult; Carcinoma, Hepatocellular; Computer Simulation; Contrast Media; Edetic Acid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Multivariate Analysis; Observer Variation; Pyridoxal Phosphate; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2002 |
Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.
Topics: Adult; Aged; Chi-Square Distribution; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Image Enhancement; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Pyridoxal Phosphate; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2002 |
Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Dextrans; Edetic Acid; False Negative Reactions; False Positive Reactions; Female; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Preoperative Care; Pyridoxal Phosphate; Sensitivity and Specificity | 2002 |
[Focal secondary malignant liver lesions: MnDPDP-enhanced MRT at 0.2 tesla vs. helical CT-arterioportography].
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Portography; Prospective Studies; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, Spiral Computed | 2002 |
Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Probability; Prospective Studies; Pyridoxal Phosphate; Radiographic Image Enhancement; Reference Values; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, Spiral Computed | 2004 |
Diagnosing biliary complications of orthotopic liver transplantation with mangafodipir trisodium-enhanced MR cholangiography: comparison with conventional MR cholangiography.
Topics: Aged; Bile Duct Diseases; Cholangiography; Contrast Media; Edetic Acid; Female; Humans; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2004 |
[Detection of liver metastases in colorectal cancer on chemotherapy. Comparative study between MRI with teslascan and computed tomography with intravenous contrast media].
Topics: Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Feasibility Studies; Humans; Injections; Iodine; Liver Neoplasms; Magnetic Resonance Imaging; Prospective Studies; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2004 |
Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Pyridoxal Phosphate | 2006 |
Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Hemangioma; Humans; Image Enhancement; Liver Abscess; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pyridoxal Phosphate; Time Factors | 2006 |
Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging.
Topics: Adult; Aged; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Humans; Image Enhancement; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Pyridoxal Phosphate; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Pharmacokinetic-pharmacodynamic modeling of manganese after a single intravenous infusion of mangafodipir in patients with acute alcoholic hepatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anesthetics, Local; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Interactions; Edetic Acid; Etoposide; Hepatitis, Alcoholic; Humans; Infusions, Intravenous; Male; Manganese; Metabolic Clearance Rate; Middle Aged; Mitoxantrone; Prednisone; Pyridoxal Phosphate; Vincristine; Young Adult | 2009 |
Contrast-enhanced MR cholangiography: comparison of Gd-EOB-DTPA and Mn-DPDP in healthy volunteers.
Topics: Adult; Bile Ducts; Cholangiography; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Male; Pyridoxal Phosphate; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.
Topics: Action Potentials; Administration, Intravenous; Aged; Animals; Antineoplastic Agents; Antioxidants; Colorectal Neoplasms; Edetic Acid; Female; Humans; Hypesthesia; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Middle Aged; Motor Activity; Muscle Contraction; Muscle, Skeletal; Nociception; Organoplatinum Compounds; Oxaliplatin; Oxidative Stress; Peripheral Nervous System Diseases; Pyridoxal Phosphate; Sciatic Nerve; Survival Analysis | 2014 |
Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction.
Topics: Dose-Response Relationship, Drug; Edetic Acid; Feasibility Studies; Female; Follow-Up Studies; Heart Ventricles; Humans; Infusions, Intravenous; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Percutaneous Coronary Intervention; Pyridoxal Phosphate; Retrospective Studies; ST Elevation Myocardial Infarction; Treatment Outcome; Ventricular Function, Left | 2015 |
Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomi
Topics: Acetaminophen; Acetylcysteine; Chemical and Drug Induced Liver Injury; Clinical Trials Data Monitoring Committees; Clinical Trials, Phase I as Topic; Data Interpretation, Statistical; Drug Overdose; Drug Therapy, Combination; Edetic Acid; Female; Humans; Male; Outcome Assessment, Health Care; Pyridoxal Phosphate; Randomized Controlled Trials as Topic; Research Design | 2019 |
Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial).
Topics: Acetaminophen; Acetylcysteine; Adult; Biomarkers; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Overdose; Edetic Acid; Female; Humans; Male; Protective Agents; Pyridoxal Phosphate; Time Factors; Young Adult | 2019 |
215 other study(ies) available for edetic acid and pyridoxal phosphate
| Article | Year |
|---|---|
Arginine decarboxylase from a Pseudomonas species.
Topics: Aminooxyacetic Acid; Ammonium Sulfate; Arginine; Carboxy-Lyases; Cell-Free System; Chemical Fractionation; Chloromercuribenzoates; Chromatography, Gel; Edetic Acid; Hydrogen-Ion Concentration; Magnesium; Polyamines; Pseudomonas; Pyridoxal Phosphate; Stereoisomerism | 1976 |
L-Glutamate-glyoxylate aminotransferase in Lactobacillus plantarum.
Topics: Azides; Cell-Free System; Cyanides; Edetic Acid; Glutamates; Glycine; Glyoxylates; Hydrogen-Ion Concentration; Hydroxylamines; Isoniazid; Ketoglutaric Acids; Lactobacillus; Magnesium; Pyridoxal Phosphate; Temperature; Transaminases | 1975 |
Sarcoplasmic reticulum adenosine triphosphatase: labeling of an essential lysyl residue with pyridoxal-5'-phosphate.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Borohydrides; Calcium; Edetic Acid; Kinetics; Lysine; Magnesium; Peptide Fragments; Pyridoxal; Pyridoxal Phosphate; Rabbits; Sarcoplasmic Reticulum | 1977 |
Relationship between microsomal membrane permeability and the inhibition of hepatic glucose-6-phosphatase by pyridoxal phosphate.
Topics: Animals; Biological Transport; Borohydrides; Edetic Acid; Glucose-6-Phosphatase; Kinetics; Male; Microsomes, Liver; Models, Biological; Permeability; Pyridoxal Phosphate; Rats | 1976 |
Regional distribution and properties of the glycine cleavage system within the central nervous system of the rat: evidence for an endogenous inhibitor during in vitro assay.
Topics: Amino Acids; Animals; Brain; Dithiothreitol; Edetic Acid; Glycine; Glycine Hydroxymethyltransferase; Medulla Oblongata; Mesencephalon; NAD; Organ Specificity; Pons; Pyridoxal Phosphate; Rats; Spinal Cord; Succinate Dehydrogenase; Telencephalon; Tetrahydrofolates | 1976 |
A branched-chain amino acid aminotransferase from the rumen ciliate genus Entodinium.
Topics: Animals; Chloromercuribenzoates; Chromatography, DEAE-Cellulose; Chromatography, Gel; Ciliophora; Dialysis; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Glutathione; Hydrogen-Ion Concentration; Isoleucine; Ketoglutaric Acids; Leucine; Molecular Weight; Pyridoxal Phosphate; Rumen; Transaminases; Valine | 1975 |
Pyridoxal-5'-phosphate as a cofactor for rat brain histidine decarboxylase.
Topics: Animals; Apoenzymes; Borohydrides; Brain; Buffers; Carboxy-Lyases; Cysteine; Dialysis; Edetic Acid; Female; Histidine Decarboxylase; Hydroxylamines; In Vitro Techniques; Isoniazid; Male; Phenylhydrazines; Pyridoxal Phosphate; Rats; Semicarbazides | 1978 |
Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
Topics: Adult; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pyridoxal Phosphate | 1992 |
Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 1992 |
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Gallbladder; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Statistical; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Time Factors | 1992 |
Contrast-enhanced MR imaging of the liver.
Topics: Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Pyridoxal Phosphate | 1992 |
Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
Topics: Animals; Barium Sulfate; Contrast Media; Digestive System; Dogs; Edetic Acid; Ferric Compounds; Fluoroscopy; Gadolinium; Gadolinium DTPA; Gastrointestinal Transit; Image Enhancement; Magnetic Resonance Imaging; Manganese; Models, Structural; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Quaternary Ammonium Compounds | 1992 |
[The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Drug Evaluation; Edetic Acid; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Prospective Studies; Pyridoxal Phosphate | 1991 |
Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients.
Topics: Biliary Tract; Contrast Media; Drug Evaluation; Drug Tolerance; Edetic Acid; Germany; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate | 1991 |
Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.
Topics: Contrast Media; Drug Evaluation; Edetic Acid; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate | 1991 |
Clinical hepatic imaging with paramagnetic positive enhancers.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver; Liver Neoplasms; Manganese; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1991 |
Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.
Topics: Animals; Contrast Media; Dogs; Drug Evaluation, Preclinical; Edetic Acid; Female; Lethal Dose 50; Liver; Magnetic Resonance Imaging; Male; Manganese; Manganese Poisoning; Mice; Pyridoxal Phosphate; Rats; Tissue Distribution | 1991 |
Pancreatic enhancement after low-dose infusion of Mn-DPDP.
Topics: Contrast Media; Edetic Acid; Humans; Image Enhancement; Infusions, Intravenous; Liver; Magnetic Resonance Imaging; Male; Manganese; Pancreas; Pyridoxal Phosphate; Time Factors | 1991 |
Manganese dipyridoxyl diphosphate. Effect of dose, time, and pulse sequence on hepatic enhancement in rats.
Topics: Animals; Contrast Media; Edetic Acid; Liver; Magnetic Resonance Imaging; Male; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1991 |
Methods for the systematic investigation of gastrointestinal contrast media for MRI: evaluation of intestinal distribution by radiographic monitoring.
Topics: Administration, Oral; Animals; Contrast Media; Digestive System; Dogs; Edetic Acid; Fluoroscopy; Gastrointestinal Transit; Magnetic Resonance Imaging; Pyridoxal Phosphate | 1991 |
[The allosteric nature of substrate inhibition of rabbit skeletal muscle fructose-1,6-diphosphatase].
Topics: Adenosine Monophosphate; Allosteric Regulation; Animals; Catalysis; Dithionitrobenzoic Acid; Edetic Acid; Fructose-Bisphosphatase; Kinetics; Magnesium; Muscles; Pyridoxal Phosphate; Rabbits; Salicylates | 1990 |
Reversible and irreversible injury in the reperfused myocardium: differentiation with contrast material-enhanced MR imaging.
Topics: Animals; Contrast Media; Edetic Acid; Female; Magnetic Resonance Imaging; Male; Muscles; Myocardial Reperfusion Injury; Myocardium; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1990 |
Advantages of a new anticoagulant in routine hematology on the Coulter Counter S-Plus STKR analyzer.
Topics: Anticoagulants; Blood Cell Count; Blood Platelets; Citrates; Drug Combinations; Edetic Acid; Humans; Platelet Aggregation; Platelet Count; Pyridoxal Phosphate; Reference Values; Tromethamine | 1990 |
Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent.
Topics: Animals; Carcinoma; Drug Evaluation, Preclinical; Edetic Acid; Image Enhancement; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Pyridoxal Phosphate; Rabbits; Time Factors | 1990 |
Liver-specific contrast agents for MRI.
Topics: Acetates; Animals; Contrast Media; Dextrans; Edetic Acid; Ethylenediamines; Ferrosoferric Oxide; Ferrous Compounds; Iron; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Rats | 1990 |
MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
Topics: Animals; Cholestasis; Chromium; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Male; Manganese; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1990 |
Double inhibition of L-threonine dehydratase by aminothiols.
Topics: Animals; Binding Sites; Binding, Competitive; Cysteamine; Cysteine; Dithiothreitol; Edetic Acid; Liver; Male; Pyridoxal Phosphate; Rats; Rats, Inbred Strains; Threonine Dehydratase | 1989 |
Determination of plasma pyridoxal phosphate levels using a modified apotryptophanase assay.
Topics: Apoenzymes; Blood Specimen Collection; Cations, Divalent; Copper; Edetic Acid; Evaluation Studies as Topic; Humans; Lyases; Methods; Pyridoxal Phosphate; Reference Values; Tryptophanase | 1989 |
Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging.
Topics: Animals; Edetic Acid; Female; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1989 |
Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP.
Topics: Animals; Blood Pressure; Contrast Media; Coronary Circulation; Coronary Disease; Edetic Acid; In Vitro Techniques; Magnetic Resonance Imaging; Myocardium; Oxygen Consumption; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1989 |
MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
Topics: Animals; Chemical and Drug Induced Liver Injury; Contrast Media; Edetic Acid; Ethanol; Galactosamine; Liver; Liver Diseases; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Rabbits; Time Factors | 1989 |
Decarboxylation of 1,2,3,4-tetrahydro-beta-carboline-1-carboxylic acids in brain homogenate and catalysis by pyridoxal-5'-phosphate.
Topics: Animals; Brain; Carbolines; Dose-Response Relationship, Drug; Edetic Acid; Mass Spectrometry; Mercury; Mice; Pyridoxal Phosphate | 1986 |
Mobilization of ferritin iron in erythroblasts by chelating agents.
Topics: Animals; Chelating Agents; Edetic Acid; Erythroblasts; Ferritins; Heptanoates; In Vitro Techniques; Iron; Pyridoxal Phosphate; Triturus | 1985 |
Delta-aminolevulinic acid synthetase activity in normal human bone marrow and in patients with idiopathic sideroblastic anemia.
Topics: 5-Aminolevulinate Synthetase; Aged; Anemia, Sideroblastic; Bone Marrow; Carbon Radioisotopes; Chromatography, Ion Exchange; Edetic Acid; Glycine; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Ketoglutarate Dehydrogenase Complex; Kinetics; Levulinic Acids; Middle Aged; Pyridoxal Phosphate; Time Factors | 1973 |
Purification and properties of glycogen phosphorylase a from the muscle of the blue crab, Callinectes danae.
Topics: Ammonium Sulfate; Animals; Brachyura; Centrifugation, Density Gradient; Chromatography; Chromatography, Gel; Dialysis; Drug Stability; Edetic Acid; Electrophoresis, Disc; Freeze Drying; Molecular Weight; Muscles; Phosphorylases; Pyridoxal Phosphate; Rabbits; Species Specificity; Starch; Time Factors | 1974 |
Purification and properties of 5-hydroxytryptophan decarboxylase from monkey small intestine.
Topics: 5-Hydroxytryptophan; Amines; Animals; Aspartic Acid; Benzoates; Carboxy-Lyases; Edetic Acid; Glutamates; Glutathione; Haplorhini; Histidine; Intestine, Small; Keto Acids; Kinetics; Male; Mercaptoethanol; Metals; Phenylalanine; Pyridoxal Phosphate; Tryptophan; Tyrosine | 1970 |
Pyridoxal and pyridoxamine phosphate breakdown by an acid phosphatase preparation.
Topics: Acid Phosphatase; Acid-Base Equilibrium; Chemical Phenomena; Chemistry; Colorimetry; Cysteine; Edetic Acid; Fluorides; Histidine; Hydrogen-Ion Concentration; Iodoacetates; Magnesium; Mercaptoethanol; Phosphoric Monoester Hydrolases; Pyridoxal Phosphate; Triticum | 1966 |
Characterization and measurement of delta-aminolaevulinate synthetase in bone marrow cell mitochondria.
Topics: Acyltransferases; Amino Acids; Animals; Bone Marrow; Bone Marrow Cells; Carbon Isotopes; Coenzyme A; Edetic Acid; Glycine; Heme; Hemoglobins; Hot Temperature; Iron Isotopes; Ketoglutaric Acids; Levulinic Acids; Lyases; Magnesium; Methods; Microchemistry; Microscopy, Electron; Mitochondria; NAD; Porphyrins; Pyridoxal Phosphate; Rabbits; Succinate Dehydrogenase; Succinates | 1968 |
Regulation of rabbit liver fructose diphosphatase. I. Reversible inactivation by oxidized glutathione.
Topics: Animals; Cations, Divalent; Edetic Acid; Fructose-Bisphosphatase; Glutathione; Homocysteine; Hydrogen-Ion Concentration; Ligands; Liver; Magnesium; Manganese; Oxidation-Reduction; Proteins; Pyridoxal; Pyridoxal Phosphate; Rabbits; Sulfhydryl Compounds | 1973 |
Enzymic pathway for thyroxine synthesis through p-hydroxy-3,5-diiodophenylpyruvic acid.
Topics: Animals; Chloromercuribenzoates; Diiodotyrosine; Edetic Acid; Ethylmaleimide; Glucose Oxidase; In Vitro Techniques; Iodine Isotopes; Iodoacetates; Isomerases; Ketoglutaric Acids; Peroxidases; Phenylpyruvic Acids; Pyridoxal Phosphate; Rats; Thyroid Gland; Thyroxine; Transaminases; Tyrosine Transaminase | 1969 |
-Aminolevulinic acid synthetase activity of human bone marrow erythroid cells in various hematological disorders.
Topics: 5-Aminolevulinate Synthetase; Anemia, Hypochromic; Anemia, Sideroblastic; Bone Marrow; Bone Marrow Cells; Carbon Isotopes; Coenzyme A; Edetic Acid; Erythrocytes; Glycine; Hematologic Diseases; Hematopoietic Stem Cells; Heme; Humans; Hydrogen-Ion Concentration; Ketoglutaric Acids; Levulinic Acids; Magnesium; Porphyrias; Pyridoxal Phosphate; Thalassemia | 1972 |
Further properties of the diamine oxidase of pea seedlings.
Topics: Amine Oxidase (Copper-Containing); Amines; Catalysis; Copper; Edetic Acid; Flavin-Adenine Dinucleotide; Hydrazines; In Vitro Techniques; Lysine; Ornithine; Phenanthrolines; Plants, Edible; Pyridoxal Phosphate | 1964 |
Enzymatic formation of beta-cyanoalanine from cyanide.
Topics: Adenosine Triphosphate; Alanine; Chemical Phenomena; Chemistry; Chloromercuribenzoates; Cyanides; Cysteine; Edetic Acid; Hydroxylamines; Indicators and Reagents; Isoniazid; Magnesium; Mercury; Plants; Pyridoxal Phosphate; Semicarbazides; Serine | 1965 |
The inactivation of pea-seedling diamine oxidase by peroxidase and 1,5-diaminopentane.
Topics: Aldehydes; Amine Oxidase (Copper-Containing); Amines; Catechols; Edetic Acid; Glutarates; Histamine; Hydrogen-Ion Concentration; Kinetics; Oxygen Consumption; Peroxidases; Piperidines; Plants, Edible; Pyridines; Pyridoxal Phosphate; Pyridoxine; Spectrophotometry | 1967 |
Purification of the alliin lyase of garlic, Allium sativum L.
Topics: Chemical Phenomena; Chemistry; Chromatography, Gel; Cobalt; Cold Temperature; Cysteine; Drug Stability; Edetic Acid; Garlic; Glycerol; Hydrogen-Ion Concentration; Hydroxylamines; Iron; Kinetics; Lyases; Magnesium; Manganese; Plants, Medicinal; Pyridoxal Phosphate; Spectrophotometry; Sulfoxides; Time Factors | 1968 |
The effect of lead and ferrous and ferric iron on delta-aminolaevulic acid synthetase.
Topics: Amino Acids; Animals; Chickens; Coenzyme A; Edetic Acid; Erythrocytes; Glycine; In Vitro Techniques; Iron; Ketoglutaric Acids; Lead; Levulinic Acids; Ligases; Magnesium; Pyridoxal Phosphate | 1969 |
[Threonine deaminease from Arthrobacter strain 23].
Topics: Alanine; Aminobutyrates; Aminoisobutyric Acids; Arthrobacter; Binding Sites; Bromides; Carbohydrates; Cell-Free System; Chemical Precipitation; Culture Media; Edetic Acid; Enzyme Activation; Hydro-Lyases; Hydrogen-Ion Concentration; Isoleucine; Leucine; Pyridoxal Phosphate; Quaternary Ammonium Compounds; Sulfates; Threonine; Ultracentrifugation; Valine; Vibration | 1971 |
[Therapy of porphyrias].
Topics: Acute Disease; Adenine Nucleotides; Antimalarials; Bicarbonates; Bloodletting; Deferoxamine; Diet Therapy; Edetic Acid; Humans; Phospholipids; Porphyrias; Pyridoxal Phosphate; Radiation-Protective Agents; Renal Dialysis | 1971 |
Threonine deaminase (dehydratase) in Azotobacter chroococcum.
Topics: Adenosine Monophosphate; Ammonia; Arsenic; Aspartic Acid; Azotobacter; Butyrates; Chromatography; Cyanides; Edetic Acid; Enzyme Activation; Fluorides; Glutamates; Hydro-Lyases; Hydrogen-Ion Concentration; Keto Acids; Kinetics; Potassium; Pyridoxal Phosphate; Quinolines; Serine; Sulfites; Thiocarbamates; Threonine | 1971 |
Clearance and metabolism of plasma pyridoxal 5'-phosphate in the dog.
Topics: Alkaline Phosphatase; Animals; Dogs; Edetic Acid; Female; Gastrectomy; Hepatectomy; Humans; Intestine, Small; Kinetics; Male; Nephrectomy; Pyridoxal Phosphate; Pyridoxine; Serum Albumin; Splenectomy | 1984 |
Covalent modification of the solubilized rat liver vitamin K-dependent carboxylase with pyridoxal-5'-phosphate.
Topics: Animals; Carbon-Carbon Ligases; Chemical Phenomena; Chemistry; Edetic Acid; Enzyme Activation; In Vitro Techniques; Ligases; Magnesium; Microsomes, Liver; Oligopeptides; Pyridoxal Phosphate; Rats; Solubility | 1984 |
Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate--, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart.
Topics: Animals; Chlorides; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Heart; Hemodynamics; In Vitro Techniques; Male; Manganese; Manganese Compounds; Perfusion; Pyridoxal Phosphate; Rats; Rats, Wistar | 1995 |
Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy.
Topics: Animals; Carbon Radioisotopes; Contrast Media; Dogs; Edetic Acid; Female; Magnetic Resonance Imaging; Male; Pyridoxal Phosphate; Rats | 1994 |
Enhancement of pancreas and diagnosis of pancreatitis using manganese dipyridoxyl diphosphate.
Topics: Animals; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Pancreas; Pancreatitis; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 1994 |
Mangafodipir (MnDPDP)-and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries.
Topics: Acetylcholine; Animals; Calcium; Cattle; Chlorides; Cyclic GMP; Edetic Acid; Endothelium, Vascular; In Vitro Techniques; Manganese Compounds; Mesenteric Arteries; Nitric Oxide; Pyridoxal Phosphate; Vasodilation | 1994 |
Comparison of L-aspartate 4-carboxy-lyases of Cunninghamella elegans and Penicillium citrinum.
Topics: Alanine; Carboxy-Lyases; Decarboxylation; Edetic Acid; Enzyme Activation; Glutathione; Hydrogen-Ion Concentration; Iodoacetates; Iodoacetic Acid; Keto Acids; Kinetics; Mercaptoethanol; Metals; Mucorales; Penicillium; Pyridoxal Phosphate; Temperature | 1994 |
Manganese dipyridoxal diphosphate-enhanced magnetic resonance imaging in the evaluation of hepatocyte function.
Topics: Animals; Contrast Media; Edetic Acid; Ethanol; Liver; Magnetic Resonance Imaging; Male; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 1993 |
Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images.
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Hemangioma, Cavernous; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Pyridoxal Phosphate; Retrospective Studies | 1994 |
The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization.
Topics: Angiography; Animals; Contrast Media; Edetic Acid; Heterocyclic Compounds; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Microradiography; Organometallic Compounds; Pyridoxal Phosphate; Rats; Rats, Wistar | 1993 |
Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
Topics: Angiography; Animals; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Manganese; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Rats, Wistar | 1993 |
Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study.
Topics: Angiography; Animals; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Liver Neoplasms; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Neoplasm Transplantation; Pyridoxal Phosphate; Rabbits; Rats; Rats, Wistar | 1993 |
Magnetic resonance imaging after arterial portography with manganese dipyridoxal diphosphate.
Topics: Animals; Contrast Media; Edetic Acid; Injections, Intra-Arterial; Injections, Intravenous; Kidney; Liver; Magnetic Resonance Imaging; Male; Mesenteric Artery, Superior; Pancreas; Pyridoxal Phosphate; Spleen; Swine; Time Factors | 1993 |
Hepatobiliary contrast material: a magic bullet for sensitivity and specificity?
Topics: Contrast Media; Edetic Acid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, X-Ray Computed | 1993 |
Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats.
Topics: Abnormalities, Drug-Induced; Animals; Bone and Bones; Chlorides; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Female; Injections, Intravenous; Limb Deformities, Congenital; Male; Manganese Compounds; Manganese Poisoning; Morphogenesis; Pregnancy; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Reproduction; Teratogens | 1995 |
Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP.
Topics: Animals; Bile Ducts; Contrast Media; Edetic Acid; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Manganese; Mice; Mice, Inbred BALB C; Pyridoxal Phosphate | 1996 |
Spectroscopic monitoring of the cellular internalization of paramagnetic ions and their complexes: a perifused cells and perfused organs approach.
Topics: Adenosine Triphosphate; Animals; Chlorides; Contrast Media; Edetic Acid; Electron Spin Resonance Spectroscopy; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Manganese Compounds; Myocardial Contraction; Myocardium; Pancreatin; Perfusion; Phosphocreatine; Pyridoxal Phosphate; Rats; Rats, Wistar; Tissue Distribution | 1996 |
Comparative assessment of gadoxetate disodium, manganese dipyridoxal diphosphate, and superparamagnetic iron oxide for enhancement of the liver in dogs.
Topics: Animals; Contrast Media; Dogs; Edetic Acid; Female; Ferrosoferric Oxide; Gadolinium DTPA; Image Enhancement; Iron; Kidney; Liver; Magnetic Resonance Imaging; Male; Organometallic Compounds; Oxides; Pentetic Acid; Pyridoxal Phosphate; Sex Factors | 1996 |
Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
Topics: Adipose Tissue; Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Liver Diseases; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Organometallic Compounds; Pancreas; Pentetic Acid; Pyridoxal Phosphate | 1996 |
Developmental toxicity study of mangafodipir trisodium injection (MnDPDP) in New Zealand white rabbits.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Contrast Media; Edetic Acid; Embryonic and Fetal Development; Female; Fetal Death; Injections, Intravenous; Pregnancy; Pyridoxal Phosphate; Rabbits; Reproduction | 1996 |
CT and MR imaging of the liver using liver-specific contrast media. A comparative study in a tumour model.
Topics: Animals; Contrast Media; Edetic Acid; Liposomes; Liver; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Manganese; Neoplasm Transplantation; Pyridoxal Phosphate; Rabbits; Tomography, X-Ray Computed; Triiodobenzoic Acids | 1996 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Pyridoxal Phosphate; Tomography, X-Ray Computed | 1996 |
The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine.
Topics: Animals; Binding, Competitive; Biological Transport; Contrast Media; Edetic Acid; Liver; Male; Manganese; Mice; Mice, Inbred Strains; Molecular Structure; Pyridoxal Phosphate; Pyridoxine | 1996 |
Effects of MnDPDP, DPDP--, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart.
Topics: Animals; Chlorides; Contrast Media; Edetic Acid; Energy Metabolism; Heart; Male; Manganese; Manganese Compounds; Myocardium; Perfusion; Pyridoxal Phosphate; Rats; Rats, Wistar; Time Factors | 1997 |
Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents.
Topics: Animals; Brain; Chlorides; Contrast Media; Edetic Acid; Injections, Intravenous; Magnetic Resonance Imaging; Male; Manganese; Manganese Compounds; Mice; Pentetic Acid; Pyridoxal Phosphate; Tissue Distribution | 1997 |
Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Reproducibility of Results; Sensitivity and Specificity; Zinc Compounds | 1997 |
Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: in vitro metabolism and protein binding studies of the active component MnDPDP in human blood.
Topics: Blood Proteins; Chromatography, High Pressure Liquid; Contrast Media; Edetic Acid; Female; Humans; Ligands; Magnetic Resonance Imaging; Male; Manganese; Pyridoxal Phosphate; Zinc Compounds | 1997 |
The need for effective contrast agents to enhance the performance of MR imaging.
Topics: Animals; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate | 1997 |
Metabolism and pharmacokinetics of MnDPDP in man.
Topics: Chromatography, High Pressure Liquid; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Feces; Humans; Male; Manganese; Pyridoxal Phosphate; Reference Values; Time Factors | 1997 |
Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration.
Topics: Animals; Carbon Radioisotopes; Contrast Media; Dogs; Edetic Acid; Female; Half-Life; Injections, Intravenous; Ligands; Male; Manganese; Pregnancy; Pyridoxal Phosphate; Radioisotopes; Rats; Rats, Sprague-Dawley; Time Factors; Tissue Distribution; Whole-Body Counting | 1997 |
Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2.
Topics: Animals; Chlorides; Contrast Media; Edetic Acid; Injections, Intravenous; Magnetic Resonance Imaging; Manganese; Manganese Compounds; Pyridoxal Phosphate; Random Allocation; Rats; Rats, Wistar; Time Factors; Tissue Distribution | 1997 |
NMR relaxation studies with MnDPDP.
Topics: Animals; Chlorides; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Magnetic Resonance Spectroscopy; Male; Manganese; Manganese Compounds; Pyridoxal Phosphate; Rats; Rats, Wistar; Spectrophotometry, Atomic; Swine; Time Factors; Tissue Distribution | 1997 |
MnDPDP enhancement in rabbit liver after intravenous bolus injection and slow infusion.
Topics: Animals; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Female; Infusions, Intravenous; Injections, Intravenous; Liver; Magnetic Resonance Imaging; Male; Manganese; Pyridoxal Phosphate; Rabbits; Random Allocation; Time Factors | 1997 |
Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction.
Topics: Animals; Cholestasis, Extrahepatic; Common Bile Duct; Contrast Media; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Edetic Acid; Ligation; Magnetic Resonance Imaging; Male; Manganese; Prognosis; Pyridoxal Phosphate; Safety; Tissue Distribution | 1997 |
Cardiovascular effects of MnDPDP and MnCl2 in dogs with acute ischaemic heart failure.
Topics: Acute Disease; Animals; Cardiovascular System; Chlorides; Contrast Media; Depression, Chemical; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Edetic Acid; Female; Heart Failure; Hemodynamics; Male; Manganese; Manganese Compounds; Myocardial Ischemia; Pyridoxal Phosphate; Time Factors | 1997 |
The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit.
Topics: Abnormalities, Drug-Induced; Animals; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Female; Fertility; Injections, Intravenous; Male; Manganese; Manganese Poisoning; Pregnancy; Prenatal Exposure Delayed Effects; Pyridoxal Phosphate; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Reproduction | 1997 |
Physicochemical characterisation of mangafodipir trisodium.
Topics: Chemical Phenomena; Chemistry, Physical; Contrast Media; Crystallization; Crystallography, X-Ray; Edetic Acid; Manganese; Molecular Structure; Pyridoxal Phosphate; Solutions; Spectrum Analysis | 1997 |
Spectroscopic and metabolic effects of MnCl2 and MnDPDP on the isolated and perfused rat heart.
Topics: Adenosine Triphosphate; Animals; Chlorides; Coronary Circulation; Dose-Response Relationship, Drug; Edetic Acid; Heart; Heart Rate; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Manganese Compounds; Myocardium; Phosphocreatine; Pyridoxal Phosphate; Rats; Rats, Wistar; Ventricular Pressure | 1997 |
Pancreatic contrast enhancement with Mn-bis pyridoxal ethylene diamine diacetic acid and the influence of a hormonal stimulation of the pancreas in pigs.
Topics: Animals; Contrast Media; Edetic Acid; Magnetic Resonance Imaging; Manganese; Pancreas; Pyridoxal Phosphate; Secretin; Spectrophotometry, Atomic; Stimulation, Chemical; Swine; Time Factors | 1994 |
Effect of manganese dipyridoxal diphosphate on liver magnetic resonance imaging and serum bilirubin in rats with removable biliary obstruction.
Topics: Animals; Bilirubin; Cholestasis; Contrast Media; Disease Models, Animal; Edetic Acid; Liver; Magnetic Resonance Imaging; Male; Pyridoxal Phosphate; Rats; Rats, Wistar; Statistics, Nonparametric | 1995 |
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Body Water; Brain; Carcinoid Tumor; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Dose-Response Relationship, Drug; Edetic Acid; Female; Humans; Image Enhancement; Infusions, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pyridoxal Phosphate; Safety; Sensitivity and Specificity; Time Factors | 1998 |
Chemical modification of dextransucrase from Leuconostoc mesenteroides NRRL B-512F by pyridoxal 5'-phosphate: evidence for the presence of an essential lysine residue at the active site.
Topics: Binding Sites; Dextrans; Edetic Acid; Enzyme Activation; Glucose; Glucosyltransferases; Kinetics; Leuconostoc; Lysine; Pyridoxal Phosphate; Spectrometry, Fluorescence; Sucrose | 1998 |
Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs.
Topics: Abdomen; Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pancreas; Pyridoxal Phosphate; Spleen | 1998 |
Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties?
Topics: Animals; Antioxidants; Cardiotonic Agents; Catalase; Contrast Media; Edetic Acid; Electron Spin Resonance Spectroscopy; Heart; In Vitro Techniques; Magnetic Resonance Imaging; Oxidative Stress; Pyridoxal Phosphate; Rats; Rats, Wistar | 1999 |
Detection of acute myocardial ischemia using first-pass dynamics of MnDPDP on inversion recovery echoplanar imaging.
Topics: Animals; Contrast Media; Dose-Response Relationship, Drug; Echo-Planar Imaging; Edetic Acid; Female; Image Processing, Computer-Assisted; Manganese; Myocardial Ischemia; Myocardium; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Sequence optimization in mangafodipir trisodium-enhanced liver and pancreas MRI.
Topics: Adult; Contrast Media; Edetic Acid; Humans; Liver; Magnetic Resonance Imaging; Male; Manganese; Pancreas; Pyridoxal Phosphate | 1999 |
Mangafodipir trisodium: effects on T2- and T1-weighted MR cholangiography.
Topics: Adult; Biliary Tract; Cholecystectomy; Cholestasis; Contrast Media; Cystic Duct; Edetic Acid; Female; Humans; Image Processing, Computer-Assisted; Manganese; Pyridoxal Phosphate | 1999 |
Cardiac metal contents after infusions of manganese. An experimental evaluation in the isolated rat heart.
Topics: Animals; Calcium; Chlorides; Contrast Media; Edetic Acid; Heart; In Vitro Techniques; Iron; Magnesium; Magnetic Resonance Imaging; Male; Manganese; Manganese Compounds; Myocardial Contraction; Myocardium; Perfusion; Pyridoxal Phosphate; Rats; Rats, Wistar; Zinc | 1999 |
Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate. Ex vivo assessments in normally perfused and ischemic guinea pig hearts.
Topics: Animals; Contrast Media; Coronary Circulation; Edetic Acid; Guinea Pigs; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Manganese; Myocardial Contraction; Myocardial Ischemia; Myocardium; Perfusion; Protons; Pyridoxal Phosphate; Ventricular Function, Left; Ventricular Pressure | 1999 |
Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model.
Topics: Analysis of Variance; Animals; Contrast Media; Coronary Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Echo-Planar Imaging; Edetic Acid; Female; Follow-Up Studies; Magnetic Resonance Imaging; Manganese; Metabolic Clearance Rate; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 2000 |
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Image Enhancement; Liver Abscess; Liver Diseases; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2000 |
Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Manganese; Pyridoxal Phosphate | 2001 |
The value of MnDPDP enhancement during MR guided laser interstitial thermoablation of liver tumors.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Laser Coagulation; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2001 |
Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy.
Topics: Adult; Bile Ducts, Intrahepatic; Cholangiography; Contrast Media; Echo-Planar Imaging; Edetic Acid; Female; Fourier Analysis; Humans; Image Enhancement; Imaging, Three-Dimensional; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2001 |
Determination of mangafodipir trisodium and related impurities in bulk substance and pharmaceutical formulation by ion-pair high-performance liquid chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Contrast Media; Edetic Acid; Pyridoxal Phosphate; Quality Control; Reference Standards | 2001 |
Dephosphorylation of MnDPDP and related compounds by acid and alkaline phosphatase.
Topics: Acid Phosphatase; Alkaline Phosphatase; Contrast Media; Edetic Acid; Phosphorylation; Pyridoxal Phosphate | 2001 |
Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; Cost-Benefit Analysis; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2001 |
Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma.
Topics: Adult; Aged; Angiomyolipoma; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Pyridoxal Phosphate; Retrospective Studies; Tomography, X-Ray Computed | 2001 |
Contrast-enhanced magnetic resonance cholangiography versus heavily T2-weighted magnetic resonance cholangiography.
Topics: Bile Ducts; Common Bile Duct; Contrast Media; Cystic Duct; Edetic Acid; Humans; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate | 2001 |
Contrast-enhanced MR imaging in the diagnosis and preservation of cardiac viability.
Topics: Animals; Cardiotonic Agents; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Myocardial Ischemia; Pyridoxal Phosphate; Swine | 2001 |
Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Contrast Media; Coronary Circulation; Disease Models, Animal; Edetic Acid; Female; Magnetic Resonance Imaging; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pyridoxal Phosphate; Swine | 2001 |
Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings.
Topics: Adult; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Gadolinium; Granuloma, Plasma Cell; Humans; Iron; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Suspensions | 2002 |
Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR.
Topics: Binding, Competitive; Biotransformation; Cations, Divalent; Contrast Media; Drug Stability; Edetic Acid; Electron Spin Resonance Spectroscopy; Humans; Magnetic Resonance Imaging; Manganese; Protein Binding; Pyridoxal Phosphate; Serum Albumin | 2002 |
Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
Topics: Adult; Aged; Chi-Square Distribution; Contrast Media; Edetic Acid; Female; Humans; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Preoperative Care; Pyridoxal Phosphate; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2002 |
Thallium-like test for myocardial viability with MnDPDP-enhanced MRI.
Topics: Animals; Contrast Media; Edetic Acid; Magnetic Resonance Imaging; Manganese; Myocardial Infarction; Myocardium; Pyridoxal Phosphate; Rats | 2002 |
Development of contrast-enhanced virtual MR cholangioscopy: a feasibility study.
Topics: Bile Ducts; Contrast Media; Edetic Acid; Endoscopy; Feasibility Studies; Humans; Image Enhancement; Magnetic Resonance Imaging; Pyridoxal Phosphate; User-Computer Interface | 2002 |
[MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation].
Topics: Ampulla of Vater; Biopsy, Needle; Common Bile Duct Neoplasms; Contrast Media; Edetic Acid; Humans; Image Enhancement; Magnetic Resonance Imaging; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate; Sensitivity and Specificity | 2002 |
Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients.
Topics: Adult; Aged; Bile Ducts; Cholecystectomy; Contrast Media; Edetic Acid; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Pyridoxal Phosphate | 2002 |
Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, X-Ray Computed | 2002 |
Liver lesion detection and characterization with sequential use of hepatobiliary contrast agent mangafodipir trisodium and gadolinium-DTPA in a single imaging protocol.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Statistics, Nonparametric | 2002 |
Exploring multifunctional features of necrosis avid contrast agents.
Topics: Animals; Contrast Media; Edetic Acid; Gadolinium DTPA; Half-Life; Liver Diseases; Liver Neoplasms; Mesoporphyrins; Metalloporphyrins; Myocardial Infarction; Necrosis; Organic Chemicals; Pyridoxal Phosphate; Rats; Rhabdomyosarcoma; Swine; Tissue Distribution | 2002 |
Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography.
Topics: Adult; Biliary Tract; Cholangiography; Contrast Media; Edetic Acid; Female; Hepatectomy; Humans; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Male; Middle Aged; Preoperative Care; Pyridoxal Phosphate; Retrospective Studies | 2002 |
Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
Topics: Animals; Contrast Media; Dogs; Edetic Acid; Image Enhancement; Magnetic Resonance Imaging; Manganese; Pancreas; Pyridoxal Phosphate | 2002 |
[MnDPDP--contrast medium with protective effect in acute myocardial infarction].
Topics: Animals; Cardiotonic Agents; Contrast Media; Edetic Acid; Mice; Mice, Transgenic; Myocardial Infarction; Myocardial Reperfusion Injury; Pyridoxal Phosphate; Swine | 2002 |
Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
Topics: Adult; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Pyridoxal Phosphate; Retrospective Studies | 2002 |
T1 efficacy of EVP-ABD: a potential manganese-based MR contrast agent for hepatic vascular and tissue phase imaging.
Topics: Animals; Aorta; Contrast Media; Edetic Acid; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Swine | 2002 |
Breast carcinoma metastases to the liver simulating cirrhosis.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Middle Aged; Pyridoxal Phosphate | 2002 |
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Cholangiocarcinoma; Contrast Media; Edetic Acid; Female; Focal Nodular Hyperplasia; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2002 |
MnDPDP-enhanced magnetization transfer MR imaging: implications for effective liver imaging.
Topics: Contrast Media; Edetic Acid; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Phantoms, Imaging; Pyridoxal Phosphate | 2003 |
[Organ specific MRI contrast media in general practice].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Neoplasm Staging; Neoplasms; Organ Specificity; Oxides; Pancreatic Neoplasms; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, Spiral Computed | 2002 |
Acute cholecystitis at T2-weighted and manganese-enhanced T1-weighted MR cholangiography: preliminary study.
Topics: Acute Disease; Adult; Aged; Cholangiography; Cholecystitis; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Pyridoxal Phosphate | 2003 |
Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology.
Topics: Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Time Factors | 2004 |
Noninvasive preoperative evaluation of biliary anatomy in right-lobe living donors with mangafodipir trisodium-enhanced MR cholangiography.
Topics: Cholangiography; Contrast Media; Edetic Acid; Humans; Liver; Living Donors; Magnetic Resonance Imaging; Pyridoxal Phosphate; Tissue and Organ Harvesting | 2003 |
Improved image contrast with mangafodipir trisodium (MnDPDP) during MR-guided percutaneous cryosurgery of the liver.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Contrast Media; Cryosurgery; Edetic Acid; Female; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Retrospective Studies | 2003 |
[Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2003 |
PURIFICATION AND PROPERTIES OF INDUCIBLE HYDROXYPROLINE 2-EPIMERASE FROM PSEUDOMONAS.
Topics: Amino Acid Isomerases; Chromatography; Dialysis; Edetic Acid; Electrophoresis; Enzyme Inhibitors; Glutathione; Hydroxyproline; Isomerases; Molecular Weight; Pharmacology; Phosphorus Isotopes; Pseudomonas; Pyridoxal Phosphate; Renal Dialysis; Research; Ultracentrifugation | 1964 |
PURIFICATION AND PROPERTIES OF THE ALANINE RACEMASE FROM BACILLUS SUBTILIS.
Topics: Alanine; Alanine Racemase; Amino Acid Oxidoreductases; Animals; Bacillus subtilis; Cattle; D-Amino-Acid Oxidase; Dialysis; Edetic Acid; Electrophoresis; Flavin Mononucleotide; Flavin-Adenine Dinucleotide; Glutathione; Hot Temperature; Isomerases; Mercury; NAD; NADP; Oxidoreductases; Pharmacology; Pyridoxal Phosphate; Renal Dialysis; Research; Serum Albumin; Serum Albumin, Bovine; Streptomycin | 1964 |
ACETYLORNITHINE DELTA-TRANSAMINASE. PARTIAL PURIFICATION AND REPRESSION BEHAVIOR.
Topics: Arginine; Benzoates; Chloromercuribenzoates; Copper; Edetic Acid; Enzyme Inhibitors; Enzyme Repression; Escherichia coli; Keto Acids; Ketoglutaric Acids; Mutation; Ornithine; Pharmacology; Pyridoxal Phosphate; Pyruvates; Research; Spectrophotometry; Transaminases | 1964 |
CORRELATES OF STRUCTURAL CHANGES IN LIVER MICROSOMAL SUSPENSIONS.
Topics: Adenosine Triphosphate; Amobarbital; Ascorbic Acid; Azides; Benzoates; Chloromercuribenzoates; Coenzyme A; Cyanides; Dicumarol; Dinitrophenols; Edetic Acid; Fluorides; Glutathione; Iodoacetates; Liver; Microsomes; Microsomes, Liver; NAD; NADP; Phosphates; Pyridoxal Phosphate; Rats; Suspensions; Thyroxine | 1964 |
Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography.
Topics: Biliary Tract; Biliary Tract Diseases; Cholecystitis; Contrast Media; Edetic Acid; Female; Gallbladder; Humans; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Predictive Value of Tests; Pyridoxal Phosphate; Sensitivity and Specificity | 2003 |
Intraoperative contrast-enhanced MR-imaging as predictor of tissue damage during cryoablation of porcine liver.
Topics: Animals; Contrast Media; Cryosurgery; Edetic Acid; Intraoperative Care; Liver; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Swine | 2003 |
Mangafodipir prevents liver injury induced by acetaminophen in the mouse.
Topics: Acetaminophen; Animals; Antibodies, Monoclonal; Antioxidants; Carcinoma, Hepatocellular; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cytochromes c; Edetic Acid; Enzymes; fas Receptor; Female; Glutathione; Humans; Liver; Liver Failure, Acute; Liver Neoplasms; Mice; Mice, Inbred BALB C; Oxidoreductases; Pyridoxal Phosphate; Reactive Oxygen Species; Superoxides; Survival Analysis | 2003 |
Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience.
Topics: Adolescent; Adult; Bile Ducts; Cholangiography; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Imaging, Three-Dimensional; Liver; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2004 |
[Contribution of MR cholangiography after Teslascan infusion for the diagnosis of post-traumatic biliary injury].
Topics: Adult; Bile Ducts; Cholangiography; Contrast Media; Edetic Acid; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Pyridoxal Phosphate | 2004 |
Assessment of sequential enhancement patterns of focal nodular hyperplasia and hepatocellular carcinoma on mangafodipir trisodium enhanced MR imaging.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Focal Nodular Hyperplasia; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2004 |
Antioxidant activity of mangafodipir is not a new finding.
Topics: Animals; Antioxidants; Cardiotonic Agents; Edetic Acid; Liver Failure, Acute; Mice; Pyridoxal Phosphate; Rats; Swine | 2004 |
Small (
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2004 |
Uptake of MnCl2 and mangafodipir trisodium in the myocardium: a magnetic resonance imaging study in pigs.
Topics: Animals; Contrast Media; Edetic Acid; Female; Magnesium Chloride; Magnetic Resonance Imaging; Male; Models, Animal; Myocardium; Pyridoxal Phosphate; Swine | 2004 |
MR imaging of the stomach: potential use for mangafodipir trisodium--a study in swine.
Topics: Animals; Contrast Media; Drug Evaluation, Preclinical; Duodenogastric Reflux; Edetic Acid; Gadolinium DTPA; In Vitro Techniques; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Stomach; Swine | 2004 |
Mangafodipir-enhanced magnetic resonance cholangiography for the diagnosis of bile duct leaks.
Topics: Adult; Aged; Bile Ducts; Contrast Media; Edetic Acid; Female; Humans; Liver; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Postoperative Complications; Prospective Studies; Pyridoxal Phosphate | 2004 |
Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging.
Topics: Contrast Media; Edetic Acid; Endosonography; Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay.
Topics: Adult; Aged; Biliary Tract Diseases; Cholangiography; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate | 2004 |
Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate; Retrospective Studies; Sensitivity and Specificity | 2004 |
MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Pyridoxal Phosphate; ROC Curve; Sensitivity and Specificity | 2004 |
Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Contrast Media; Dextrans; Diagnosis, Differential; Edetic Acid; Female; Ferrosoferric Oxide; Humans; Image Enhancement; Infusions, Intravenous; Injections, Intravenous; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Pyridoxal Phosphate; ROC Curve | 2004 |
Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric mangafodipir trisodium enhanced magnetic resonance cholangiography.
Topics: Adult; Bile Ducts; Cholangiography; Contrast Media; Edetic Acid; Humans; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Predictive Value of Tests; Preoperative Care; Prospective Studies; Pyridoxal Phosphate | 2004 |
Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography.
Topics: Adolescent; Adult; Bile Ducts, Intrahepatic; Cholangiography; Contrast Media; Edetic Acid; Female; Hepatectomy; Humans; Image Enhancement; Imaging, Three-Dimensional; Intraoperative Care; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Radiography, Interventional; Statistics, Nonparametric | 2004 |
Early biliary complications of laparoscopic cholecystectomy: evaluation on T2-weighted MR cholangiography in conjunction with mangafodipir trisodium-enhanced 3D T1-weighted MR cholangiography.
Topics: Adult; Aged; Aged, 80 and over; Bile Ducts; Cholangiopancreatography, Magnetic Resonance; Cholecystectomy, Laparoscopic; Contrast Media; Edetic Acid; Female; Humans; Injections, Intravenous; Male; Middle Aged; Postoperative Complications; Pyridoxal Phosphate | 2004 |
Relaxation enhancing properties of MnDPDP in human myocardium.
Topics: Adult; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Electrocardiography; Female; Heart Rate; Humans; Liver; Magnetic Resonance Imaging; Male; Manganese; Myocardial Contraction; Myocardium; Pyridoxal Phosphate | 2004 |
Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part I: comparison with pathologic examination.
Topics: Acute Disease; Animals; Cats; Contrast Media; Disease Models, Animal; Edetic Acid; Magnetic Resonance Imaging; Myocardial Reperfusion Injury; Pyridoxal Phosphate | 2005 |
Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part II: comparison with cine magnetic resonance imaging.
Topics: Acute Disease; Animals; Cats; Contrast Media; Disease Models, Animal; Edetic Acid; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Myocardial Reperfusion Injury; Pyridoxal Phosphate | 2005 |
Double gallbladder diagnosed on contrast-enhanced MR cholangiography with mangafodipir trisodium.
Topics: Cholangiopancreatography, Magnetic Resonance; Contrast Media; Edetic Acid; Female; Gallbladder; Humans; Middle Aged; Pyridoxal Phosphate | 2005 |
Biliary atresia: feasibility of mangafodipir trisodium-enhanced MR cholangiography for evaluation.
Topics: Biliary Atresia; Cholangiography; Contrast Media; Edetic Acid; Feasibility Studies; Female; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Prospective Studies; Pyridoxal Phosphate; Sensitivity and Specificity | 2005 |
MR cholangiography with manganese dipyridoxyl diphosphate in the evaluation of biliary-enteric anastomoses: preliminary experience.
Topics: Adult; Aged; Anastomosis, Surgical; Bile Ducts, Intrahepatic; Cholangiopancreatography, Magnetic Resonance; Constriction, Pathologic; Contrast Media; Edetic Acid; Female; Humans; Male; Middle Aged; Postoperative Complications; Pyridoxal Phosphate; Statistics, Nonparametric | 2005 |
On the AJR viewbox. Intrapancreatic accessory spleen: diagnosis with RES-specific contrast-enhanced MRI.
Topics: Choristoma; Contrast Media; Diagnosis, Differential; Edetic Acid; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Diseases; Pyridoxal Phosphate; Spleen | 2005 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
[MR and biliary tract].
Topics: Biliary Tract; Biliary Tract Diseases; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Pyridoxal Phosphate | 2005 |
Hepatocyte-targeted MR contrast agents: contrast enhanced detection of liver cancer in diffusely damaged liver.
Topics: Animals; Carbon Tetrachloride; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Hepatitis, Animal; Hepatocytes; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxides; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 2005 |
The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity.
Topics: Antineoplastic Agents; Biomimetic Materials; Contrast Media; Edetic Acid; Hydrogen Peroxide; Pyridoxal Phosphate; Superoxide Dismutase | 2006 |
[Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks].
Topics: Abdominal Injuries; Adolescent; Adult; Aged; Bile; Bile Duct Diseases; Biliary Fistula; Cholecystectomy; Contrast Media; Drainage; Edetic Acid; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Postoperative Complications; Pyridoxal Phosphate; Retrospective Studies; Sensitivity and Specificity | 2006 |
Mangafodipir trisodium-enhanced MR imaging of pancreatic disease.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pancreatic Diseases; Prospective Studies; Pyridoxal Phosphate; Sensitivity and Specificity | 2006 |
Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity.
Topics: Acetylcysteine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Edetic Acid; Humans; Hydrogen Peroxide; Leukocytes; Mice; Oxidation-Reduction; Pyridoxal Phosphate; Reactive Oxygen Species | 2006 |
Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Catalase; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Confidence Intervals; Drug Synergism; Edetic Acid; Female; Fluorouracil; Glutathione Reductase; Humans; Hydrogen Peroxide; Leukocytes; Mice; Mice, Inbred BALB C; Organoplatinum Compounds; Oxaliplatin; Oxidative Stress; Paclitaxel; Pyridoxal Phosphate; Reactive Oxygen Species; Staphylococcal Infections; Staphylococcus aureus; Superoxide Dismutase; Superoxides | 2006 |
Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 2006 |
Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Echinococcosis, Hepatic; Edetic Acid; Female; Focal Nodular Hyperplasia; Hemangioma; Humans; Image Enhancement; Infusions, Intravenous; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2006 |
An apparent unidirectional influx constant for manganese as a measure of myocardial calcium channel activity.
Topics: Adult; Calcium Channels; Contrast Media; Echo-Planar Imaging; Edetic Acid; Female; Humans; Image Interpretation, Computer-Assisted; Ion Channel Gating; Kinetics; Male; Metabolic Clearance Rate; Myocardium; Pyridoxal Phosphate; Radiopharmaceuticals; Reference Values | 2006 |
Contrast enhanced cartilage imaging: Comparison of ionic and non-ionic contrast agents.
Topics: Animals; Arthrography; Cartilage, Articular; Cattle; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Patellar Ligament; Pyridoxal Phosphate; Sodium Chloride; Time Factors | 2007 |
[New possibilities to study biliary tree and gallbladder: functional magnetic resonance cholangiography contrast-enhanced with mangafodipir trisodium (Mn DPDP)].
Topics: Adult; Aged; Anastomosis, Surgical; Bile Duct Diseases; Bile Ducts, Intrahepatic; Biliary Tract Diseases; Choledochal Cyst; Contrast Media; Echo-Planar Imaging; Edetic Acid; Female; Gallbladder Diseases; Humans; Image Enhancement; Imaging, Three-Dimensional; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Postoperative Complications; Pyridoxal Phosphate; Time Factors | 2007 |
Re: diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Topics: Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Pyridoxal Phosphate | 2007 |
Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction.
Topics: Adult; Aged; Biomarkers; Contrast Media; Coronary Vessels; Echocardiography; Edetic Acid; Female; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Pyridoxal Phosphate; Treatment Outcome | 2007 |
Axon tracing in the adult rat optic nerve and tract after intravitreal injection of MnDPDP using a semiautomatic segmentation technique.
Topics: Analysis of Variance; Animals; Chlorides; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Imaging, Three-Dimensional; Injections; Magnetic Resonance Imaging; Manganese Compounds; Optic Nerve; Pyridoxal Phosphate; Rats; Rats, Inbred F344; Regression Analysis; Tissue Distribution; Vitreous Body | 2008 |
Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Prospective Studies; Pyridoxal Phosphate; ROC Curve; Sensitivity and Specificity | 2008 |
[Value of MRCP with Mangafodipir Trisodium (Teslascan) injection in the diagnosis and management of bile leaks].
Topics: Adolescent; Adult; Aged; Anastomosis, Surgical; Bile; Bile Ducts; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Cystic Duct; Drainage; Edetic Acid; Endoscopy, Digestive System; Female; Hepatectomy; Hepatic Duct, Common; Humans; Image Enhancement; Male; Manganese; Middle Aged; Postoperative Complications; Pyridoxal Phosphate; Retrospective Studies; Survival Rate; Treatment Outcome | 2007 |
Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.
Topics: Adenocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2007 |
The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cell Differentiation; Contrast Media; Edetic Acid; Female; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Pyridoxal Phosphate | 2008 |
Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2009 |
Mangafodipir as a cytoprotective adjunct to chemotherapy--a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cholangitis, Sclerosing; Colectomy; Colonic Neoplasms; Crohn Disease; Cytoprotection; Edetic Acid; Fluorouracil; Humans; Leucovorin; Male; Palliative Care; Pyridoxal Phosphate; Young Adult | 2009 |
Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Pyridoxal Phosphate; Secretin; Tomography, X-Ray Computed | 2009 |
Tumor models and specific contrast agents for small animal imaging in oncology.
Topics: Animals; Biomarkers, Tumor; Clinical Trials as Topic; Contrast Media; Diagnostic Imaging; Disease Models, Animal; Edetic Acid; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Models, Animal; Molecular Diagnostic Techniques; Neoplasm Transplantation; Neoplasms, Experimental; Pyridoxal Phosphate; Rhabdomyosarcoma | 2009 |
Toward clinical application of manganese-enhanced MRI of retinal function.
Topics: Adaptation, Ocular; Animals; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Image Enhancement; Magnetic Resonance Imaging; Male; Manganese; Models, Statistical; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Retina | 2010 |
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Topics: Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2009 |
Manganese-enhanced MRI of hypoxic-ischemic brain injuries using Mn-DPDP.
Topics: Animals; Animals, Newborn; Contrast Media; Edetic Acid; Female; Hypoxia-Ischemia, Brain; Magnetic Resonance Imaging; Manganese; Pregnancy; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 2009 |
Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
Topics: Aged; Colorectal Neoplasms; Contrast Media; Dextrans; Edetic Acid; Fatty Liver; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pyridoxal Phosphate; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Prevention of 7β-hydroxycholesterol-induced cell death by mangafodipir is mediated through lysosomal and mitochondrial pathways.
Topics: Cell Death; Cell Line; Cell Membrane Permeability; Edetic Acid; Hydroxycholesterols; Lysosomes; Mitochondria; Oxidative Stress; Pyridoxal Phosphate; Reactive Oxygen Species | 2010 |
In vitro neurotoxicity of magnetic resonance imaging (MRI) contrast agents: influence of the molecular structure and paramagnetic ion.
Topics: Animals; Cells, Cultured; Contrast Media; Edetic Acid; Gadolinium DTPA; Lactate Dehydrogenases; Magnetic Resonance Imaging; Neurons; Pyridoxal Phosphate; Rats | 2010 |
Magnetic resonance cholangiography with mangafodipir trisodium in Caroli's disease with pancreas involvement.
Topics: Adult; Caroli Disease; Cholangiography; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Pancreas; Pancreatic Diseases; Pyridoxal Phosphate | 2010 |
Mangafodipir protects against hepatic ischemia-reperfusion injury in mice.
Topics: Animals; Apoptosis; Aspartate Aminotransferases; Edetic Acid; Female; Glutathione; Ischemic Preconditioning; Lipid Peroxidation; Liver; Mice; Mice, Inbred BALB C; Pyridoxal Phosphate; Reactive Oxygen Species; Reperfusion Injury; Survival Rate | 2011 |
The platelet count in EDTA-anticoagulated blood from patients with thrombocytopenia may be underestimated when measured in routine laboratories.
Topics: Adult; Aged; Aged, 80 and over; Agglutination; Anticoagulants; Blood Platelets; Chelating Agents; Citrates; Diagnostic Errors; Drug Combinations; Edetic Acid; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Count; Pyridoxal Phosphate; Risk; Thrombocytopenia; Time Factors; Tromethamine; Young Adult | 2012 |
Enhanced tissue differentiation in the developing mouse brain using magnetic resonance micro-histology.
Topics: Animals; Brain; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Pyridoxal Phosphate; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Catalase; Edetic Acid; Gene Expression; Graft Survival; Heme Oxygenase-1; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Peroxidation; Liver; Liver Transplantation; Male; Nitric Oxide Synthase; Organ Culture Techniques; Organ Preservation; Organ Preservation Solutions; Primary Graft Dysfunction; Pyridoxal Phosphate; Rats; Reactive Oxygen Species; Transplantation Tolerance | 2012 |
Effects of Mn-DPDP and manganese chloride on hemodynamics and glucose tolerance in anesthetized rats.
Topics: Animals; Chlorides; Contrast Media; Edetic Acid; Glucose Tolerance Test; Hemodynamics; Islets of Langerhans; Magnetic Resonance Imaging; Male; Manganese Compounds; Microspheres; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 2014 |
Fodipir and its dephosphorylated derivative dipyridoxyl ethyldiamine are involved in mangafodipir-mediated cytoprotection against 7β-hydroxycholesterol-induced cell death.
Topics: Cell Death; Cell Membrane Permeability; Cytoprotection; Edetic Acid; Humans; Hydroxycholesterols; Lysosomes; Membrane Potential, Mitochondrial; Protective Agents; Pyridoxal Phosphate; Reactive Oxygen Species; U937 Cells | 2013 |
The search for treatments to reduce chemotherapy-induced peripheral neuropathy.
Topics: Animals; Antineoplastic Agents; Antioxidants; Edetic Acid; Female; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyridoxal Phosphate | 2014 |
Breaking away from the norm: a new perspective on cancer therapeutics.
Topics: Animals; Antineoplastic Agents; Contrast Media; Edetic Acid; Humans; Neoplasms; Pyridoxal Phosphate; Quality of Life | 2014 |
[Cancer, reactive oxygen species and chemotherapy-induced peripheral neuropathy].
Topics: Animals; Antineoplastic Agents; Edetic Acid; Humans; Neoplasms; Peripheral Nervous System Diseases; Pyridoxal Phosphate; Reactive Oxygen Species; Superoxide Dismutase | 2014 |
A new opportunity for MEMRI.
Topics: Animals; Chlorides; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Manganese Compounds; Mice, Transgenic; Neurodegenerative Diseases; Pyridoxal Phosphate | 2017 |
Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line; Cell Line, Tumor; Cisplatin; Contrast Media; Edetic Acid; Female; Granulosa Cells; Humans; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Ovarian Follicle; Ovary; Oxidative Stress; Paclitaxel; Protective Agents; Pyridoxal Phosphate; Xenograft Model Antitumor Assays | 2018 |
Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: stud
Topics: Acetaminophen; Acetylcysteine; Drug Overdose; Edetic Acid; Humans; Pyridoxal Phosphate; Research Design | 2019 |
Manganese-Enhanced MRI of the Brain in Healthy Volunteers.
Topics: Adult; Brain; Contrast Media; Edetic Acid; Female; Healthy Volunteers; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Pyridoxal Phosphate | 2019 |
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir?
Topics: Acetaminophen; Acetylcysteine; Edetic Acid; Humans; Pyridoxal Phosphate; Superoxide Dismutase | 2019 |
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir? - Authors' reply.
Topics: Acetaminophen; Acetylcysteine; Edetic Acid; Humans; Pyridoxal Phosphate; Superoxide Dismutase | 2019 |
Manganese-Enhanced MRI in Patients with Multiple Sclerosis.
Topics: Adult; Animals; Contrast Media; Edetic Acid; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Pilot Projects; Pyridoxal Phosphate | 2020 |
Assessment of stunned and viable myocardium using manganese-enhanced MRI.
Topics: Adult; Calcium; Contrast Media; Edetic Acid; Female; Follow-Up Studies; Humans; Intracellular Space; Magnetic Resonance Imaging, Cine; Male; Manganese; Middle Aged; Myocardial Stunning; Myocardium; Pyridoxal Phosphate; Retrospective Studies | 2021 |